SUPPORTED CATALYST SYSTEMS CONTAINING A SILOCON BRIDGED, ANTHRACENYL SUBSTITUTED BIS-BIPHENYL-PHENOXY ORGANOMETALLIC COMPOUND FOR MAKING POLYETHYLENE AND POLYETHYLENE COPOLYMER RESINS IN A GAS PHASE POLYMERIZATION REACTOR TECHNICAL FIELD [0001] Embodiments of the present disclosure are generally directed to supported catalyst systems for use in a gas phase polymerization reactor and, in particular, to a supported silicon bridged anthracenyl substituted bis-phenyl-phenoxy catalyst system for use in a gas phase polymerization reactor. BACKGOUND [0002] Since the discovery of Ziegler and Natta on heterogeneous olefin polymerizations, global polyolefin production reached approximately 150 million tons per year in 2015, and continues to increase due to market demand. The catalyst systems in the polyolefin polymerization process may contribute to the characteristics and properties of such polyolefins. For example, catalyst systems that include bis-phenyl-phenoxy (BPP) metal-ligand complexes may produce polyolefins that have flat or reverse short-chain branching distributions (SCBD), relatively high levels of comonomer incorporation, high native molecular weights, and/or narrow- medium molecular weight distributions (MWD). [0003] However, when utilized in some polymerization processes, such as gas-phase polymerization, catalyst systems that include BPP metal-ligand complexes may exhibit generally poor productivity. That is, catalyst systems that include BPP metal-ligand complexes may generally produce less polymer relative to the amount of the catalyst system used. Therefore, the use of catalyst systems that include BPP metal-ligand complexes may not be commercially viable in gas-phase polymerization processes. SUMMARY [0004] Accordingly, ongoing needs exist for supported catalyst systems that are suitable for use in gas-phase reactors and have improved productivity when utilized in gas-phase polymerization processes. Embodiments of the present disclosure address these needs by providing supported catalyst systems for use in gas-phase polymerization processes, where the supported catalyst system exhibits, among other attributes, a greatly increased productivity when compared to similar catalyst systems including BPP metal-ligand complexes without silicon bridged anthracenyl substituted bis-phenyl-phenoxy catalyst systems of the present disclosure.    

[0005] Embodiments of the present disclosure include a supported catalyst system in which a metal-ligand complex of formula (I) is disposed on one or more support materials. The metal- ligand complex has a structure according to formula (I): I) [0006] In formula )n is 1, 2, or 3; each X is a monodentate ligand independently chosen from (C1-C50)hydrocarbyl, (C ₁ −C ₅₀ )heterohydrocarbyl, (C ₆ −C ₅₀ )aryl, (C ₄ −C ₅₀ )heteroaryl, halogen, –N(R ^N ) ₂ , –N(R ^N )COR ^C , –OR, –OPh, –OAr and -H; and the metal-ligand complex of formula (I) is overall charge-neutral (prior to being disposed on support materials as discussed herein). [0007] In formula (I), each Z is independently chosen from –O−, −S−, (C6−C50)aryl, (C ₂ −C ₅₀ )heteroaryl, N(C ₁ −C ₅₀ )hydrocarbyl, N(C ₁ -C ₅₀ )aryl, P(C ₁ -C ₅₀ )aryl, and P(C1−C50)hydrocarbyl. [0008] In formula (I), R ⁹ and R ¹⁰ are independently chosen from (C ₁ −C ₂₀ )hydrocarbyl, (C1−C20)heterohydrocarbyl and -H. [0009] In formula (I), R ¹¹ and R ¹² are independently chosen from halogen, (C1−C20)hydrocarbyl, (C1−C20)heterohydrocarbyl and -H. [0010] In formula (I), R ¹ −R ⁸ are each independently (C ₁ −C ₂₀ )hydrocarbyl, (C1−C20)heterohydrocarbyl and -H. [0011] In formula (I), R ¹³ and R ¹⁴ are independently chosen from (C ₁ −C ₂₀ )hydrocarbyl, (C1−C20)heterohydrocarbyl and -H. [0012] In formula (I), R ¹⁵ and R ¹⁶ are independently chosen from (C ₁ −C ₂₀ )hydrocarbyl, (C1−C20)heterohydrocarbyl and -H.     [0013] In formula (I), R ¹⁷ and R ¹⁸ are both: (C ₁ -C ₂₀ )hydrocarbyl, (C ₁ -C ₂₀ ) heterohydrocarbyl, or -H, where R ^19-23 are independently chosen from (C ₁ −C ₂₀ )hydrocarbyl, erohydrocarbyl and -H. [0014] In formula (I) each R, R ^C and R ^N are independently chosen from −H, (C1−C50)hydrocarbyl, and (C1−C50)heterohydrocarbyl. [0015] In some embodiments, at least two R groups of R ^19-23 are (C ₁ −C ₂₀ )hydrocarbyl. In some embodiments, when R ¹¹ and R ¹² are halogen, R ¹ , R ⁴ , R ⁵ and R ⁸ are each independently (C ₁ −C ₂₀ )hydrocarbyl and R ² , R ³ , R ⁶ and R ⁷ are -H or R ¹ , R ⁴ , R ⁵ and R ⁸ are each -H and R ² , R ³ , R ⁶ and R ⁷ are each independently (C1−C20)hydrocarbyl. [0016] The supported catalyst system of the present disclosure can also be spray-dried to form a spray-dried supported catalyst system. [0017] The supported catalyst system of the present disclosure can also be spray-dried to form a spray-dried supported catalyst system. [0018] The supported catalyst system of the present disclosure can further include one or more activators. [0019] Embodiments of the present disclosure include methods for producing supported activated metal-ligand catalyst. The method includes contacting one or more support materials and one or more activators with the metal-ligand complex (I) in an inert hydrocarbon solvent to produce the supported activated metal-ligand catalyst having a structure according to formula (Ib): R ¹⁷ R ¹⁸ R ² R ⁶

, where A- is an anion, and where M; subscript n of (X)n; each X; each Z; R ¹ , R ⁴ , R ⁵ and R ⁸ ; R ² , R ³ , R ⁶ and R ⁷ ; R ⁹ and R ¹⁰ ; R ¹¹ and R ¹² ; R ¹³ and R ¹⁴ ; R ¹⁵ and R ¹⁶ ; R ¹⁷ and R ¹⁸ ; R, R ^C and R ^N ; and R ¹⁹ through R ²³ are as described previously with regard to the metal-ligand complex of formula (I) and formula I(a), as provided herein. [0020] Embodiments of the present disclosure include methods for spray-drying the supported activated metal-ligand catalyst to produce a spray-dried supported activated metal-ligand catalyst, as discussed herein. [0021] Embodiments of the present disclosure include a process for producing a polyethylene or polyethylene copolymer resin in a gas phase polymerization reactor under effective gas-phase polymerization conditions. The process includes contacting ethylene and, optionally, one or more (C3−C12)α-olefin comonomers with the supported activated metal-ligand catalyst or spray-dried supported activated metal-ligand catalyst of the present disclosure in a gas phase polymerization reactor under effective gas-phase polymerization conditions. [0022] These and additional features provided by the embodiments of the present disclosure will be more fully understood in view of the following detailed description. DETAILED DESCRIPTION [0023] Specific embodiments of supported catalyst systems, spray-dried supported catalyst systems, methods of producing supported catalyst systems and spray-dried supported catalyst systems, and processes for producing polyethylene and polyethylene copolymer resins will now be described. However, the systems, methods, and processes of the present disclosure may be embodied in different forms and should not be construed as limited to the specific embodiments set forth in the present disclosure. Rather, embodiments are provided so that the present disclosure will be thorough and complete, and will fully convey the scope of the disclosed subject matter to those skilled in the art. [0024] Common abbreviations used in the present disclosure are listed below: [0025] Me: methyl; Et: ethyl; Ph: phenyl; Bn: benzyl; i-Pr: iso-propyl; t-Bu: tert-butyl; t- Octyl: tert-octyl (2,4,4-trimethylpentan-2-yl); Tf: trifluoromethane sulfonate; THF: tetrahydrofuran; Et ₂ O: diethyl ether; CH ₂ Cl ₂ : dichloromethane; CV: column volume (used in column chromatography); EtOAc: ethyl acetate; C ₆ D ₆ : deuterated benzene or benzene-d6; CDCl ₃ : deuterated chloroform; Na ₂ SO ₄ : sodium sulfate; MgSO ₄ : magnesium sulfate; HCl: hydrogen chloride; n-BuLi: butyllithium; t-BuLi: tert-butyllithium; MeMgBr: methylmagnesium bromide; MAO: methylaluminoxane; MMAO: modified methylaluminoxane; GC: gas chromatography; LC: liquid chromatography; NMR: nuclear magnetic resonance; MS:    

mass spectrometry; mmol: millimoles; mL: milliliters; M: molar; min or mins: minutes; h or hrs: hours; d: days. [0026] The terms “halogen atom” or “halogen” mean the radical of a fluorine atom (F), chlorine atom (Cl), bromine atom (Br), or iodine atom (I). The term “halide” means the anionic form of the halogen atom: fluoride (F ⁻ ), chloride (Cl ⁻ ), bromide (Br ⁻ ), or iodide (I ⁻ ). [0027] The term “independently selected” means that the R groups, such as, R ¹ , R ² , and R ³ , can be identical or different (e.g., R ¹ , R ² , and R ³ may all be substituted alkyls; or R ¹ and R ² may be a substituted alkyl, and R ³ may be an aryl). A chemical name associated with an R group is intended to convey the chemical structure that is recognized in the art as corresponding to that of the chemical name. As a result, chemical names are intended to supplement and illustrate, not preclude, the structural definitions known to those of skill in the art. [0028] The term “activator” means a compound that chemically reacts with a neutral metal- ligand complex in a manner that converts this complex to a catalytically active compound. As used in the present disclosure, the terms “co-catalyst” and “activator” are interchangeable and have identical meanings unless clearly specified. [0029] The term “substitution” means that at least one hydrogen atom (−H) bonded to a carbon atom of a corresponding unsubstituted compound or functional group is replaced by a substituent (e.g., R ^S ). The term “−H” means a hydrogen or hydrogen radical that is covalently bonded to another atom. As used in the present disclosure, the terms “hydrogen” and “−H” are interchangeable and have identical meanings unless clearly specified. [0030] When used to describe certain carbon atom-containing chemical groups, a parenthetical expression having the form “(C _x −C _y )” means that the unsubstituted form of the chemical group has from x carbon atoms to y carbon atoms, inclusive of x and y. For example, a (C ₁ −C ₅₀ )alkyl is an alkyl group having from 1 to 50 carbon atoms in its unsubstituted form. In some embodiments and general structures, certain chemical groups may be substituted by one or more substituents such as R ^S . An R ^S substituted chemical group defined using the “(C _x −C _y )” parenthetical may contain more than y carbon atoms depending on the identity of any groups R ^S . For example, a “(C ₁ −C ₅₀ )alkyl substituted with exactly one group R ^S , where R ^S is phenyl (−C ₆ H ₅ )” may contain from 7 to 56 carbon atoms. As a result, when a chemical group defined using the “(C _x −C _y )” parenthetical is substituted by one or more carbon atom-containing substituents R ^S , the minimum and maximum total number of carbon atoms of the chemical group is determined by adding to both x and y the combined sum of the number of carbon atoms from all of the carbon atom-containing substituents R ^S .    

[0031] The term “(C ₁ −C ₅₀ )hydrocarbyl” means a hydrocarbon radical of from 1 to 50 carbon atoms and the term “(C1−C50)hydrocarbylene” means a hydrocarbon diradical of from 1 to 50 carbon atoms, in which each hydrocarbon radical and each hydrocarbon diradical is aromatic or non-aromatic, saturated or unsaturated, straight chain or branched chain, cyclic (having three carbons or more, and including mono- and poly-cyclic, fused and non-fused polycyclic, and bicyclic) or acyclic, and substituted by one or more R ^S or unsubstituted. As used in the present disclosure, a (C ₁ −C ₅₀ )hydrocarbyl may be an unsubstituted or substituted (C ₁ −C ₅₀ )alkyl, (C3−C50)cycloalkyl, (C3−C25)cycloalkyl-(C1−C25)alkylene, (C6−C50)aryl, or (C6−C25)aryl- (C ₁ −C ₂₅ )alkylene (such as benzyl (−CH ₂ −C ₆ H ₅ )). [0032] The term “(C1−C20)hydrocarbyl” means a hydrocarbon radical of from 1 to 20 carbon atoms and the term “(C ₁ −C ₂₀ )hydrocarbylene” means a hydrocarbon diradical of from 1 to 20 carbon atoms, in which each hydrocarbon radical and each hydrocarbon diradical is aromatic or non-aromatic, saturated or unsaturated, straight chain or branched chain, cyclic (having three carbons or more, and including mono- and poly-cyclic, fused and non-fused polycyclic, and bicyclic) or acyclic, and substituted by one or more R ^S or unsubstituted. As used in the present disclosure, a (C1−C20)hydrocarbyl may be an unsubstituted or substituted (C1−C20)alkyl, (C ₃ −C ₂₀ )cycloalkyl, (C ₃ −C ₂₀ )cycloalkyl-(C ₁ −C ₂₀ )alkylene, (C ₆ −C ₂₀ )aryl, or (C ₆ −C ₂₀ )aryl- (C1−C20)alkylene (such as benzyl (−CH2−C6H5)). [0033] The term “(C1−C50)alkyl” means a saturated straight or branched hydrocarbon radical containing from 1 to 50 carbon atoms. Each (C ₁ −C ₅₀ )alkyl may be unsubstituted or substituted by one or more R ^S . In embodiments, each hydrogen atom in a hydrocarbon radical may be substituted with R ^S , such as, for example, trifluoromethyl. Examples of unsubstituted (C ₁ −C ₅₀ )alkyl are unsubstituted (C1−C20)alkyl; unsubstituted (C1−C10)alkyl; unsubstituted (C1−C5)alkyl; methyl; ethyl; 1-propyl; 2-propyl; 1-butyl; 2-butyl; 2-methylpropyl; 1,1-dimethylethyl; 1-pentyl; 1-hexyl; 1-heptyl; 1-nonyl; and 1-decyl. Examples of substituted (C1−C50)alkyl are substituted (C ₁ −C ₂₀ )alkyl, substituted (C ₁ −C ₁₀ )alkyl, trifluoromethyl, and [C ₄₅ ]alkyl. The term “[C ₄₅ ]alkyl” means there is a maximum of 45 carbon atoms in the radical, including substituents, and is, for example, a (C ₂₇ −C ₄₀ )alkyl substituted by one R ^S , which is a (C ₁ −C ₅ )alkyl, such as, for example, methyl, trifluoromethyl, ethyl, 1-propyl, 1-methylethyl, or 1,1-dimethylethyl. [0034] The term “(C ₃ −C ₅₀ )cycloalkyl” means a saturated cyclic hydrocarbon radical of from 3 to 50 carbon atoms that is unsubstituted or substituted by one or more R ^S . Other cycloalkyl groups (e.g., (C _x −C _y )cycloalkyl) are defined in an analogous manner as having from x to y carbon atoms and being either unsubstituted or substituted with one or more R ^S . Examples of unsubstituted (C ₃ −C ₅₀ )cycloalkyl are unsubstituted (C ₃ −C ₂₀ )cycloalkyl, unsubstituted    

(C ₃ −C ₁₀ )cycloalkyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, cyclononyl, and cyclodecyl. Examples of substituted (C3−C50)cycloalkyl are substituted (C ₃ −C ₂₀ )cycloalkyl, substituted (C ₃ −C ₁₀ )cycloalkyl, and 1-fluorocyclohexyl. [0035] The term “–OAr” refers to an oxy linked (C6−C20)aryl groups and oxy linked (C ₂ −C ₂₀ )aryl groups. Such aryl groups can include, but are not limited to, naphthyl, substituted phenyl and naphthyl, furan, thiophene and pyrrole, among others. [0036] The term “(C ₆ −C ₅₀ )aryl” means an unsubstituted or substituted (by one or more R ^S ) mono-, bi- or tricyclic aromatic hydrocarbon radical of from 6 to 50 carbon atoms, of which at least from 6 to 14 of the carbon atoms are aromatic ring carbon atoms. A monocyclic aromatic hydrocarbon radical includes one aromatic ring; a bicyclic aromatic hydrocarbon radical has two rings; and a tricyclic aromatic hydrocarbon radical has three rings. When the bicyclic or tricyclic aromatic hydrocarbon radical is present, at least one of the rings of the radical is aromatic. The other ring or rings of the aromatic radical may be independently fused or non-fused and aromatic or non-aromatic. Examples of unsubstituted (C6−C50)aryl include: unsubstituted (C6−C20)aryl, unsubstituted (C ₆ −C ₁₈ )aryl; 2−(C ₁ −C ₅ )alkyl−phenyl; phenyl; fluorenyl; tetrahydrofluorenyl; indacenyl; hexahydroindacenyl; indenyl; dihydroindenyl; naphthyl; tetrahydronaphthyl; and phenanthrene. Examples of substituted (C ₆ −C ₅₀ )aryl include: substituted (C ₁ −C ₂₀ )aryl; substituted (C6−C18)aryl; 2,4−bis([C20]alkyl)−phenyl; polyfluorophenyl; pentafluorophenyl; and fluoren−9−one−l−yl. [0037] The term “heteroatom,” refers to an atom other than hydrogen or carbon. Examples of groups containing one or more than one heteroatom include O, S, S(O), S(O)2, Si(R ^C )2, P(R ^P ), N(R ^N ), −N=C(R ^C ) ₂ , −Ge(R ^C ) ₂ −, or −Si(R ^C )−, where each R ^C and each R ^P is unsubstituted (C1−C18)hydrocarbyl or −H, and where each R ^N is unsubstituted (C1−C18)hydrocarbyl. The term “heterohydrocarbon” refers to a molecule or molecular framework in which one or more carbon atoms of a hydrocarbon are replaced with a heteroatom. The term “(C1−C50)heterohydrocarbyl” means a heterohydrocarbon radical of from 1 to 50 carbon atoms, and the term “(C1−C50)heterohydrocarbylene” means a heterohydrocarbon diradical of from 1 to 50 carbon atoms. The heterohydrocarbon of the (C ₁ −C ₅₀ )heterohydrocarbyl or the (C1−C50)heterohydrocarbylene has one or more heteroatoms. The term “(C ₁ −C ₂₀ )heterohydrocarbyl” means a heterohydrocarbon radical of from 1 to 20 carbon atoms, and the term “(C1−C20)heterohydrocarbylene” means a heterohydrocarbon diradical of from 1 to 20 carbon atoms. The heterohydrocarbon of the (C ₁ −C ₂₀ )heterohydrocarbyl or the (C1−C20)heterohydrocarbylene has one or more heteroatoms. The radical of the heterohydrocarbyl may be on a carbon atom or a heteroatom. The two radicals of the heterohydrocarbylene may be    

on a single carbon atom or on a single heteroatom. Additionally, one of the two radicals of the diradical may be on a carbon atom and the other radical may be on a different carbon atom; one of the two radicals may be on a carbon atom and the other on a heteroatom; or one of the two radicals may be on a heteroatom and the other radical on a different heteroatom. Each (C ₁ −C ₂₀ )heterohydrocarbyl, (C ₁ −C ₂₀ )heterohydrocarbylene, (C ₁ −C ₅₀ )heterohydrocarbyl and (C1−C50)heterohydrocarbylene may be unsubstituted or substituted (by one or more R ^S ), aromatic or non-aromatic, saturated or unsaturated, straight chain or branched chain, cyclic (including mono- and poly-cyclic, fused and non-fused polycyclic), or acyclic. [0038] The term “(C ₄ −C ₅₀ )heteroaryl” means an unsubstituted or substituted (by one or more R ^S ) mono-, bi-, or tricyclic heteroaromatic hydrocarbon radical of from 4 to 50 total carbon atoms and from 1 to 10 heteroatoms. A monocyclic heteroaromatic hydrocarbon radical includes one heteroaromatic ring; a bicyclic heteroaromatic hydrocarbon radical has two rings; and a tricyclic heteroaromatic hydrocarbon radical has three rings. When the bicyclic or tricyclic heteroaromatic hydrocarbon radical is present, at least one of the rings in the radical is heteroaromatic. The other ring or rings of the heteroaromatic radical may be independently fused or non-fused and aromatic or non-aromatic. Other heteroaryl groups (e.g., (Cx−Cy)heteroaryl generally, such as (C ₄ −C ₁₂ )heteroaryl) are defined in an analogous manner as having from x to y carbon atoms (such as 4 to 12 carbon atoms) and being unsubstituted or substituted by one or more than one R ^S . The monocyclic heteroaromatic hydrocarbon radical is a 5-membered ring or a 6-membered ring. The 5-membered ring has 5 minus h carbon atoms, wherein h is the number of heteroatoms and may be 1, 2, or 3; and each heteroatom may be O, S, N, or P. Examples of 5-membered ring heteroaromatic hydrocarbon radicals include pyrrol-1-yl; pyrrol-2-yl; furan-3-yl; thiophen-2-yl; pyrazol-1-yl; isoxazol-2-yl; isothiazol-5-yl; imidazol-2-yl; oxazol-4-yl; thiazol-2-yl; 1,2,4-triazol- 1-yl; 1,3,4-oxadiazol-2-yl; 1,3,4-thiadiazol-2-yl; tetrazol-1-yl; tetrazol-2-yl; and tetrazol-5-yl. The 6-membered ring has 6 minus h carbon atoms, wherein h is the number of heteroatoms, and may be 1 or 2 and the heteroatoms may be N or P. Examples of 6-membered ring heteroaromatic hydrocarbon radicals include pyridine-2-yl; pyrimidin-2-yl; and pyrazin-2-yl. The bicyclic heteroaromatic hydrocarbon radical can be a fused 5,6- or 6,6-ring system. Examples of the fused 5,6-ring system bicyclic heteroaromatic hydrocarbon radical are indol-1-yl; and benzimidazole- 1-yl. Examples of the fused 6,6-ring system bicyclic heteroaromatic hydrocarbon radical are quinolin-2-yl; and isoquinolin-1-yl. The tricyclic heteroaromatic hydrocarbon radical can be a fused 5,6,5-; 5,6,6-; 6,5,6-; or 6,6,6-ring system. An example of the fused 5,6,5-ring system is 1,7- dihydropyrrolo[3,2-f]indol-1-yl. An example of the fused 5,6,6-ring system is 1H-benzo[f] indol- 1-yl. An example of the fused 6,5,6-ring system is 9H-carbazol-9-yl. An example of the fused    

6,5,6- ring system is 9H-carbazol-9-yl. An example of the fused 6,6,6-ring system is acrydin-9- yl. [0039] The terms "polymer" refer to polymeric compounds prepared by polymerizing monomers, whether of the same or a different type. The generic term polymer thus includes homopolymers, which are polymers prepared by polymerizing only one monomer, and copolymers or copolymer resins, which are polymers prepared by polymerizing two or more different types of monomers. [0040] The term "interpolymer" refers to polymers prepared by polymerizing at least two different types of monomers. The generic term interpolymer thus includes copolymers, copolymer resins and other polymers prepared by polymerizing more than two different monomers, such as terpolymers. [0041] The terms “polyolefin,” “polyolefin polymer,” and “polyolefin resin” refer to polymers prepared by polymerizing a simple olefin (also referred to as an alkene, which has the general formula CnH2n) monomer. The generic term polyolefin thus includes polymers prepared by polymerizing ethylene monomer with or without one or more comonomers, such as polyethylene, and polymers prepared by polymerizing propylene monomer with or without one or more comonomers, such as polypropylene. [0042] The terms "polyethylene" and "ethylene-based polymer" refer to polyolefins comprising greater than 50 percent (%) by mole of units that have been derived from ethylene monomer, which includes polyethylene homopolymers and copolymers. Common forms of polyethylene known in the art include Low Density Polyethylene (LDPE), Linear Low Density Polyethylene (LLDPE), Ultra Low Density Polyethylene (ULDPE), Very Low Density Polyethylene (VLDPE), Medium Density Polyethylene (MDPE), and High Density Polyethylene (HDPE). [0043] The term “molecular weight distribution” means a ratio of two different molecular weights of a polymer. The generic term molecular weight distribution includes a ratio of a weight average molecular weight (Mw) of a polymer to a number average molecular weight (Mn) of the polymer, which may also be referred to as a “molecular weight distribution (M _w /M _n ),” and a ratio of a z-average molecular weight (Mz) of a polymer to a weight average molecular weight (Mw) of the polymer, which may also be referred to as a “molecular weight distribution (M _z /M _w ).” [0044] The term “composition” means a mixture of materials that comprises the composition, as well as reaction products and decomposition products formed from the materials of the composition.    

[0045] The terms “comprising,” “including,” “having,” and their derivatives, are not intended to exclude the presence of any additional component, step, or procedure, whether or not the same is specifically disclosed. In order to avoid any doubt, all compositions claimed through use of the term “comprising” may include any additional additive, adjuvant, or compound, whether polymeric or otherwise, unless stated to the contrary. In contrast, the term, “consisting essentially of” excludes from the scope of any succeeding recitation any other component, step, or procedure, excepting those that are not essential to operability. The term “consisting of” excludes any component, step, or procedure not specifically delineated or listed. [0046] Embodiments of the present disclosure provide for a metal-ligand complex disposed on one or more support materials to provide a supported catalyst system. In particular, embodiments, the present disclosure provides for a supported catalyst system for use in a gas phase polymerization reactor for producing polyethylene from ethylene or, in particular, producing polyethylene copolymer resins from ethylene and one or more (C ₃ −C ₁₂ )α-olefin comonomers. [0047] The supported catalyst system of the present disclosure can provide for increased polyethylene and polyethylene copolymer resin productivity and efficiency in gas phase polymerization reactor systems, as seen in the Examples section herein. In addition, the polyethylene and polyethylene copolymer resins produced with the supported catalyst system of the present disclosure can exhibit additional advantageous polymer properties including linear low-to-high density, while also having higher native molecular weights. [0048] Embodiments of the present disclosure include a supported catalyst system in which a metal-ligand complex of formula (I) is disposed on one or more support materials. The metal- ligand complex has a structure according to formula (I): I) [0049] n embodiments, M is titanium, zirconium, or hafnium, each independently being in a formal oxidation state of +2,    

+3, or +4. In a specific embodiment, M is zirconium. In another specific embodiment, M is hafnium. [0050] In formula (I), subscript n of (X) _n is 1, 2, or 3, and each X is a monodentate ligand independently chosen from (C1-C50)hydrocarbyl, (C1−C50)heterohydrocarbyl, (C6−C50)aryl, (C ₄ −C ₅₀ )heteroaryl, halogen, –N(R ^N ) ₂ , –N(R ^N )COR ^C , –OR, –OPh, –OAr and -H. In embodiments, each X is independently chosen from methyl; ethyl; 1-propyl; 2-propyl; 1-butyl; 2,2,- dimethylpropyl; trimethylsilylmethyl; phenyl; benzyl; or chloro. In or more embodiments, subscript n of (X)n is 2. In some embodiments, subscript n of (X)n is 2 and each X is the same. For example, subscript n of (X) _n is 2 and each X is methyl. In other embodiments, at least two X’s are different. For example, subscript n of (X)n may be 2 and each X may be a different one of methyl; ethyl; 1-propyl; 2-propyl; 1-butyl; 2,2,-dimethylpropyl; trimethylsilylmethyl; phenyl; benzyl; and chloro. In embodiments, subscript n of (X)n is 1 or 2 and at least two X independently are monoanionic monodentate ligands and a third X, if present, is a neutral monodentate ligand. [0051] In formula (I), the metal-ligand complex is overall charge-neutral (prior to being disposed on support materials as discussed herein). [0052] In formula (I), each Z is independently chosen from –O−, −S−, (C6−C50)aryl, (C ₂ −C ₅₀ )heteroaryl, N(C ₁ −C ₅₀ )hydrocarbyl, N(C ₁ -C ₅₀ )aryl, P(C ₁ -C ₅₀ )aryl, and P(C1−C50)hydrocarbyl. In embodiments, each Z is the same. For example, each Z is –O−. [0053] In formula (I), R ⁹ and R ¹⁰ are independently chosen from (C1−C20)alkyl and -H. In some embodiments, R ⁹ and R ¹⁰ are independently chosen from (C ₁ −C ₁₀ )hydrocarbyl, (C1−C10)heterohydrocarbyl and -H. In some embodiments, each R ⁹ and R ¹⁰ is independently chosen from methyl; ethyl; 1-propyl; 2-propyl; tert-butyl; 1-butyl; 2,2,-dimethylpropyl; 1,1,- dimethyl-3,3,-dimethylbutyl or t-octyl; cyclopentyl, cyclohexyl, pentyl, 3-methyl-l-butyl, hexyl, 4-methyl-l-pentyl, heptyl, n-octyl, 1,1-dimethyloctyl, nonyl, and decyl. In some embodiments, each R ⁹ and R ¹⁰ are the same. For example, each R ⁹ and R ¹⁰ is 1,1,-dimethyl-3,3,-dimethylbutyl. In other embodiments, R ⁹ and R ¹⁰ may be a different one of methyl; ethyl; 1-propyl; 2-propyl; 1- butyl; 2,2,-dimethylpropyl; 1,1,-dimethyl-3,3,-dimethylbutyl. [0054] In formula (I), R ¹¹ and R ¹² are independently chosen from halogen, (C ₁ −C ₂₀ )alkyl and -H. In some embodiments, R ¹¹ and R ¹² are independently chosen from halogen, (C ₁ −C ₁₀ )hydrocarbyl, (C ₁ −C ₁₀ )heterohydrocarbyl and -H. In embodiments, each R ¹¹ and R ¹² in formula (I) is a halogen independently selected from the radical of a fluorine atom (F), chlorine atom (Cl), bromine atom (Br), or iodine atom (I). In some embodiments, each R ¹¹ and R ¹² in formula (I) is the same halogen. For example, R ¹¹ and R ¹² are fluorine (F). In embodiments, each R ¹¹ and R ¹² is independently chosen from methyl; ethyl; 1-propyl; 2-propyl; tert-butyl; 1-butyl;    

2,2,-dimethylpropyl; 1,1,-dimethyl-3,3,-dimethylbutyl; cyclopentyl, cyclohexyl, pentyl, 3- methyl-l-butyl, hexyl, 4-methyl-l-pentyl, heptyl, n-octyl, tert-octyl, 1,1-dimetyloctyl, nonyl, and decyl. In some embodiments, each R ¹¹ and R ¹² are the same. For example, each R ¹¹ and R ¹² is 1,1,-dimethyl-3,3,-dimethylbutyl or tert-octyl. In other embodiments, R ¹¹ and R ¹² may be a different one of methyl; ethyl; 1-propyl; 2-propyl; 1-butyl; 2,2,-dimethylpropyl; 1,1,-dimethyl- 3,3,-dimethylbutyl, tert-octyl or tert-butyl. [0055] In formula (I), R ¹ −R ⁸ are each independently (C ₁ −C ₂₀ ) hydrocarbyl, (C1−C20)heterohydrocarbyl and -H.. In some embodiments, R ¹ −R ⁸ are each independently (C ₁ −C ₁₀ )hydrocarbyl. (C ₁ −C ₁₀ )heterohydrocarbyl and -H. In some embodiments, R ¹ −R ⁸ are each independently (C1−C5)hydrocarbyl, (C1−C5)heterohydrocarbyl and -H. In some embodiments, R ¹ −R ⁸ are each independently chosen from methyl; ethyl; 1-propyl; 2-propyl; n-butyl (butyl); sec- butyl (butan-2-yl), isobutyl (2-methylpropyl), tert-butyl, n-pentyl, tert-pentyl (2-methylbutan-2- yl), neopentyl (2,2-dimethylpropyl), isopentyl (3-methylbutyl), sec-pentyl (pentan-2-yl), 3-pentyl (pentan-3-yl), sec-isopentyl (3-methylbutan-2-yl) and 2-methylbutyl and -H. In some embodiments, R ¹ −R ⁸ are each independently chosen from (C ₄ )hydrocarbyl and -H, where embodiments of the (C4)hydrocarbyl include n-butyl, sec-butyl, isobutyl and tert-butyl. In some embodiments, R ¹ , R ⁴ , R ⁵ and R ⁸ are each tert-butyl and R ² , R ³ , R ⁶ and R ⁷ are each -H. In some embodiments, R ¹ , R ⁴ , R ⁵ and R ⁸ are each -H and R ² , R ³ , R ⁶ and R ⁷ are each tert-butyl. [0056] In some embodiments, when R ¹¹ and R ¹² are halogen (e.g., a fluorine atom (F)), R ¹ , R ⁴ , R ⁵ and R ⁸ are each independently (C ₁ −C ₂₀ )hydrocarbyl and R ² , R ³ , R ⁶ and R ⁷ are -H or R ¹ , R ⁴ , R ⁵ and R ⁸ are each -H and R ² , R ³ , R ⁶ and R ⁷ are each independently (C1−C20)hydrocarbyl. In some embodiments, R ¹ −R ⁸ are each independently (C ₁ −C ₅ )hydrocarbyl and -H. In some embodiments, when R ¹¹ and R ¹² are halogen R ¹ , R ⁴ , R ⁵ and R ⁸ are each independently (C1−C5)hydrocarbyl and R ² , R ³ , R ⁶ and R ⁷ are -H or R ¹ , R ⁴ , R ⁵ and R ⁸ are each -H and R ² , R ³ , R ⁶ and R ⁷ are each independently (C1−C5)hydrocarbyl. In some embodiments, when R ¹¹ and R ¹² are halogen R ¹ , R ⁴ , R ⁵ and R ⁸ are each independently chosen from methyl; ethyl; 1-propyl; 2-propyl; n-butyl (butyl); sec-butyl (butan-2-yl), isobutyl (2-methylpropyl), tert-butyl, n-pentyl, tert-pentyl (2-methylbutan- 2-yl), neopentyl (2,2-dimethylpropyl), isopentyl (3-methylbutyl), sec-pentyl (pentan-2-yl), 3- pentyl (pentan-3-yl), sec-isopentyl (3-methylbutan-2-yl) and 2-methylbutyl, while R ² , R ³ , R ⁶ and R ⁷ are -H. In some embodiments, when R ¹¹ and R ¹² are halogen R ² , R ³ , R ⁶ and R ⁷ are each independently chosen from methyl; ethyl; 1-propyl; 2-propyl; n-butyl (butyl); sec-butyl (butan-2- yl), isobutyl (2-methylpropyl), tert-butyl, n-pentyl, tert-pentyl (2-methylbutan-2-yl), neopentyl (2,2-dimethylpropyl), isopentyl (3-methylbutyl), sec-pentyl (pentan-2-yl), 3-pentyl (pentan-3-yl), sec-isopentyl (3-methylbutan-2-yl) and 2-methylbutyl, while R ¹ , R ⁴ , R ⁵ and R ⁸ are -H. In some     embodiments, when R ¹¹ and R ¹² are halogen R ² , R ³ , R ⁶ and R ⁷ are each (C ₄ )hydrocarbyl and R ¹ , R ⁴ , R ⁵ and R ⁸ are each -H, where embodiments of the (C4)hydrocarbyl include n-butyl, sec-butyl, isobutyl and tert-butyl. In some embodiments, when R ¹¹ and R ¹² are halogen R ¹ , R ⁴ , R ⁵ and R ⁸ are each (C4)hydrocarbyl and R ² , R ³ , R ⁶ and R ⁷ are each -H, where embodiments of the (C ₄ )hydrocarbyl include n-butyl, sec-butyl, isobutyl and tert-butyl. In some embodiments, when R ¹¹ and R ¹² are halogen R ² , R ³ , R ⁶ and R ⁷ are each tert-butyl and R ¹ , R ⁴ , R ⁵ and R ⁸ are each -H. In some embodiments, when R ¹¹ and R ¹² are halogen R ¹ , R ⁴ , R ⁵ and R ⁸ are each tert-butyl and R ² , R ³ , R ⁶ and R ⁷ are each -H. In specific embodiments, for each of the above examples, R ¹¹ and R ¹² are a fluorine atom (F). [0057] In formula (I), R ¹³ and R ¹⁴ are independently chosen from (C1−C20)hydrocarbyl, (C ₁ −C ₂₀ )heterohydrocarbyl and -H. In some embodiments, R ¹³ and R ¹⁴ are independently chosen from (C1−C4)hydrocarbyl, (C1−C4)heterohydrocarbyl and -H. In some embodiments, each R ¹³ and R ¹⁴ is independently chosen from methyl; ethyl; 1-propyl; 2-propyl; n-butyl; sec-butyl, isobutyl and tert-butyl. In some embodiments, each R ¹³ and R ¹⁴ is the same. For example, each R ¹³ and R ¹⁴ is methyl. In other embodiments, R ¹³ and R ¹⁴ may be a different one of methyl; ethyl; 1- propyl; 2-propyl; n-butyl; sec-butyl, isobutyl and tert-butyl. [0058] In formula (I), R ¹⁵ and R ¹⁶ are independently chosen from (C ₁ −C ₂₀ )hydrocarbyl, (C1−C20)heterohydrocarbyl and -H. In some embodiments, R ¹⁵ and R ¹⁶ are independently chosen from (C1−C4)hydrocarbyl, (C1−C4)heterohydrocarbyl and -H. In some embodiments, each R ¹⁵ and R ¹⁶ is independently chosen from -H, methyl; ethyl; 1-propyl; 2-propyl; n-butyl; sec-butyl, isobutyl and tert-butyl. In some embodiments, each R ¹⁵ and R ¹⁶ is the same. For example, each R ¹⁵ and R ¹⁶ is -H. In other embodiments, R ¹⁵ and R ¹⁶ may be a different one of -H, methyl; ethyl; 1-propyl; 2-propyl; n-butyl; sec-butyl, isobutyl and tert-butyl. [0059] In formula (I) each R, R ^C and R ^N are independently chosen from −H, (C1−C50)hydrocarbyl, and (C1−C50)heterohydrocarbyl. [0060] In formula (I), R ¹⁷ and R ¹⁸ are both: (C ₁ -C ₂₀ )hydrocarbyl, (C ₁ -C ₂₀ )heterohydrocarbyl, or -H, where R ^19-23 are independently chosen from (C ₁ −C ₂₀ )hydrocarbyl, terohydrocarbyl and -H. The supported catalyst system of the present disclosure can further optionally include an additional caveat that at least two R groups of R ^19-23 are     (C1−C5)hydrocarbyl. For example, in some embodiments R ¹⁷ and R ¹⁸ are bot or - H, where R ^19-23 are independently chosen from (C ₁ −C ₅ )hydrocarbyl and -H w that at 1 ⁹ least two R groups of R ^-23 are (C1−C5)hydrocarbyl. [0061] In some embodiments, each R ¹⁷ and R ¹⁸ are both -H. In some embodiments, each R ¹⁷ and R ¹⁸ are bot to give the metal-ligand complex a structure according to formula (Ia): a) where M; subscript n of (X) _n , each X; each Z; R ¹ , R ⁴ , R ⁵ and R ⁸ ; R ² , R ³ , R ⁶ and R ⁷ ; R ⁹ and R ¹⁰ ; R ¹¹ and R ¹² ; R ¹³ and R ¹⁴ ; R ¹⁵ and R ¹⁶ ; R ¹⁹ through R ²³ , and R, R ^C and R ^N are as described previously with regard to the metal-ligand complex of formula (I). For some embodiments, in formula (Ia) R ^19-23 are independently chosen from (C1−C20)hydrocarbyl, (C ₁ −C ₂₀ )heterohydrocarbyl and -H. For some embodiments, in formula (Ia) R ^19-23 are independently chosen from (C1−C10)hydrocarbyl, (C1−C10)heterohydrocarbyl and -H. For some embodiments, in formula (Ia) R ^19-23 are independently chosen from (C ₁ −C ₅ )hydrocarbyl, (C1−C5)heterohydrocarbyl and -H. [0062] For the given caveat, that at least two R groups of R ^19-23 are (C ₁ −C ₂₀ )hydrocarbyl, in some embodiments, R ²⁰ and R ²² are each (C1−C20)alkyl and R ¹⁹ , R ²¹ and R ²³ are each -H. In some embodiments, R ²⁰ and R ²² are each (C ₄ )hydrocarbyl and R ¹⁹ , R ²¹ and R ²³ are each -H, where    

embodiments of the (C ₄ )hydrocarbyl include n-butyl, sec-butyl, isobutyl and tert-butyl. In some embodiments, R ²⁰ and R ²² are each tert-butyl and R ¹⁹ , R ²¹ and R ²³ are each -H. [0063] The supported catalyst system of the present disclosure can also be catalytically activated when combined with an activator. In embodiments, the supported catalyst system may be rendered catalytically active by contacting it to, or combining it with, an activator. A supported catalyst system that has been rendered catalytically active by contacting it to, or combining it with, an activator may be referred to as a “supported activated metal-ligand catalyst.” That is, as used in the present disclosure, a supported activated metal-ligand catalyst may include the supported catalyst system of the present disclosure and one or more activators. The term “activator” may include any combination of reagents that increases the rate at which a transition metal compound oligomerizes or polymerizes unsaturated monomers, such as olefins. An activator may also affect the molecular weight, degree of branching, comonomer content, or other properties of the oligomer or polymer. The supported catalyst system of the present disclosure may be activated for oligomerization and/or polymerization catalysis in any manner sufficient to allow coordination or cationic oligomerization and or polymerization. [0064] Alumoxane activators may be utilized as an activator for one or more of the supported catalyst system. Alumoxane(s) or aluminoxane(s) are generally oligomeric compounds containing --Al(R)--O-- subunits, where R is an alkyl group. Examples of alumoxanes include methylalumoxane (MAO), modified methylalumoxane (MMAO), ethylalumoxane and isobutylalumoxane. Alkylalumoxanes and modified alkylalumoxanes are suitable as catalyst activators, particularly when the abstractable ligand is a halide. Mixtures of different alumoxanes and modified alumoxanes may also be used. For further descriptions, see U.S. Patent Nos. 4,665,208; 4,952,540; 5,041,584; 5,091,352; 5,206,199; 5,204,419; 4,874,734; 4,924,018; 4,908,463; 4,968,827; 5,329,032; 5,248,801; 5,235,081; 5,157,137; 5,103,031; and EP 0561476; EP 0279586; EP 0516476; EP 0594218; and WO 94/10180. [0065] When the activator is an alumoxane (modified or unmodified), the maximum amount of activator may be selected to be a 5000-fold molar excess Al/M over the supported catalyst system (per metal catalytic site). Alternatively, or additionally the minimum amount of activator- to-supported catalyst system may be set at a 1:1 molar ratio. [0066] Aluminum alkyl or organoaluminum compounds that may be utilized as activators (or scavengers) include trimethylaluminum, triethylaluminum, triisobutylaluminum, tri-n- hexylaluminum, tri-n-octylaluminum and the like. [0067] When the metal−ligand complex is rendered catalytically active by an activator, the metal of the metal-ligand complex may have a formal charge of positive one (+1). For example,    

in embodiments in which the catalyst system includes the metal-ligand complex, the metal-ligand complex may have a structure according to formula (Ib) and has an overall formal charge of positive one (+1): R ¹⁷ R ^{18 R2} _R ^{6 3 7} b) ; R ¹ , R ⁴ , R ⁵ and R ⁸ ; R ² , R ³ , R ⁶ and R ⁷ ; R ⁹ and R ¹⁰ ; R ¹¹ and R ¹² ; R ¹³ and R ¹⁴ ; R ¹⁵ and R ¹⁶ ; R ¹⁷ and R ¹⁸ ; R, R ^C and R ^N ; and R ¹⁹ through R ²³ are as described previously with regard to the metal-ligand complex of formula (I) and formula I(a). [0069] Formula (Ib) is an illustrative depiction of an activated metal-ligand catalyst. [0070] In embodiments, the metal-ligand complex, the activator, or both, may be disposed on one or more support materials. For example, the metal-ligand complex may be deposited on, contacted with, vaporized with, bonded to, or incorporated within, adsorbed or absorbed in, or on, one or more support materials. The metal-ligand complex may be combined with one or more support materials using one of the support methods well known in the art or as described below. As used in the present disclosure, the metal-ligand complex is in a supported form, for example, when deposited on, contacted with, or incorporated within, adsorbed or absorbed in, or on, one or more support materials. [0071] Suitable support materials, such as inorganic oxides, include oxides of metals of Group 2, 3, 4, 5, 13 or 14 of the IUPAC periodic table (dated 1 December 2018). In embodiments, support materials include silica, which may or may not be dehydrated, fumed silica, alumina (e.g., as described in International Patent Application No. 1999/060033), silica-alumina, and mixtures of these. The fumed silica may be hydrophilic (untreated), alternatively hydrophobic (treated). In embodiments, the support material is hydrophobic fumed silica, which may be prepared by treating an untreated fumed silica with a treating agent, such as dimethyldichlorosilane, a    

polydimethylsiloxane fluid, or hexamethyldisilazane. In some embodiments, support materials include magnesia, titania, zirconia, magnesium chloride (e.g., as described in U.S. Patent No. 5,965,477), montmorillonite (e.g., as described in European Patent No.0511665), phyllosilicate, zeolites, talc, clays (e.g., as described in U.S. Patent No. 6,034,187), and mixtures of these. In other embodiments, combinations of these support materials may be used, such as, for example, silica-chromium, silica-alumina, silica-titania, and combinations of these. Additional support materials may also include those porous acrylic polymers described in European Patent No.0767 184. Other support materials may also include nanocomposites described in International Patent Application No. 1999/047598; aerogels described in International Patent Application No. 1999/048605; spherulites described in U.S. Patent No.5,972,510; and polymeric beads described in International Patent Application No.1999/050311. [0072] In embodiments, the support material has a surface area of from 10 square meters per gram (m ² /g) to 700 m ² /g, a pore volume of from 0.1 cubic meters per gram (cm ³ /g) to 4.0 cm ³ /g, and an average particle size of from 5 microns (µm) to 500 µm. In some embodiments, the support material has a surface area of from 50 m ² /g to 500 m ² /g, a pore volume of from 0.5 cm ³ /g to 3.5 cm ³ /g, and an average particle size of from 10 µm to 200 µm. In other embodiments, the support material may have a surface area of from 100 m ² /g to 400 m ² /g, a pore volume from 0.8 cm ³ /g to 3.0 cm ³ /g, and an average particle size of from 5 µm to 100 µm. The average pore size of the support material is typically from 10 Angstroms (Å) to 1,000 Å, such as from 50 Å to 500 Å or from 75 Å to 350 Å. [0073] There are various suitable methods to produce the supported activated metal-ligand catalyst of the present disclosure. In one or more embodiments, methods for producing the supported activated metal-ligand catalyst include contacting one or more support materials and one or more activators with the metal-ligand complex in an inert hydrocarbon solvent to produce the supported activated metal-ligand catalyst. In some embodiments, the method for producing the supported activated metal-ligand catalyst may include disposing the one or more activators on the one or more support materials to produce a supported activator and contacting the supported activator with a solution of the metal-ligand complex in an inert hydrocarbon solvent (often referred to as a “trim catalyst” or a “trim feed”). For example, in some embodiments, methods for producing the supported activated metal-ligand catalyst include contacting a spray-dried supported activator (i.e., a supported activator produced via spray drying) with a solution of the metal-ligand complex in an inert hydrocarbon solvent. In some embodiments, the supported activator may be included in a slurry, such as, for example a mineral oil slurry.    

[0074] In some embodiments, the method for producing the supported activated metal-ligand catalyst may include mixing one or more support materials, one or more activators, and the metal- ligand complex of the present disclosure to produce a catalyst system precursor. The methods may further include drying the catalyst system precursor to produce the supported activated metal- ligand catalyst. More specifically, the methods may include making a mixture of the metal-ligand complex, one or more support materials, one or more activators, or a combination of these, and an inert hydrocarbon solvent. The inert hydrocarbon solvent may then be removed from the mixture to produce the metal-ligand complex, the one or more activators, or combinations of these, disposed on the one or more support materials. In embodiments, the removing step may be achieved via conventional evaporating of the inert hydrocarbon solvent from the mixture (i.e., conventional concentrating method), which yields a supported activated metal-ligand catalyst. In other embodiments, the removing step may be achieved by spray-drying the mixture, which produces particles of the spray-dried supported activated metal-ligand catalyst. The drying and/or removing steps may not result in the complete removal of liquids from the resulting supported catalyst system. That is, the supported activated metal-ligand catalyst may include residual amounts (i.e., from 1 wt.% to 3 wt.%) of the inert hydrocarbon solvent. [0075] As noted above, the supported activated metal-ligand catalyst of the present disclosure may be utilized in processes for producing polymers, such as polyethylene and polyethylene copolymer resins, via the polymerization of olefins, such as ethylene and, optionally, one or more (C ₃ −C ₁₂ )α-olefin comonomers. In embodiments, ethylene, and optionally one or more (C ₃ −C ₁₂ )α- olefins, may be contacted with the supported catalyst systems of the present disclosure in a gas- phase polymerization reactor, such as a gas-phase fluidized bed polymerization reactor. Exemplary gas-phase systems are described in U.S. Patent Nos. 5,665,818; 5,677,375; and 6,472,484; and European Patent Nos. 0 517 868 and 0 794 200. For example, in some embodiments, ethylene and, optionally, one or more (C3−C12)α-olefin comonomers may be contacted with the supported activated metal-ligand catalyst of the present disclosure in a gas- phase polymerization reactor. The supported activated metal-ligand catalyst may be fed to the gas- phase polymerization reactor in neat form (i.e., as a dry solid), as a solution, or as a slurry. For example, in some embodiments, particles of the spray-dried supported activated metal-ligand catalyst may be fed directly to the gas-phase polymerization reactor. In other embodiments, a solution or slurry of the supported activated metal-ligand catalyst in a solvent, such as an inert hydrocarbon or mineral oil, may be fed to the reactor. For example, the supported catalyst system may be fed to the reactor in an inert hydrocarbon solution and the activator may be fed to the reactor in a mineral oil slurry.    

[0076] In embodiments, the gas-phase polymerization reactor comprises a fluidized bed reactor. A fluidized bed reactor may include a “reaction zone” and a “velocity reduction zone.” The reaction zone may include a bed of growing polymer particles, formed polymer particles, and a minor amount of the supported catalyst system fluidized by the continuous flow of the gaseous monomer and diluent to remove heat of polymerization through the reaction zone. Optionally, some of the re-circulated gases may be cooled and compressed to form liquids that increase the heat removal capacity of the circulating gas stream when readmitted to the reaction zone. A suitable rate of gas flow may be readily determined by simple experiment. Make up of gaseous monomer to the circulating gas stream may be at a rate equal to the rate at which particulate polymer product and monomer associated therewith may be withdrawn from the reactor and the composition of the gas passing through the reactor may be adjusted to maintain an essentially steady state gaseous composition within the reaction zone. The gas leaving the reaction zone may be passed to the velocity reduction zone where entrained particles are removed. Finer entrained particles and dust may be removed in a cyclone and/or fine filter. The gas may be passed through a heat exchanger where the heat of polymerization may be removed, compressed in a compressor, and then returned to the reaction zone. Additional reactor details and means for operating the reactor are described in, for example, U.S. Patent Nos. 3,709,853; 4,003,712; 4,011,382; 4,302,566; 4,543,399; 4,882,400; 5,352,749; and 5,541,270; European Patent No.0802202; and Belgian Patent No.839,380. [0077] In embodiments, the reactor temperature of the gas-phase polymerization reactor is from 30 °C to 150 °C. For example, the reactor temperature of the gas-phase polymerization reactor may be from 30 °C to 120 °C, from 30 °C to 110 °C, from 30 °C to 100 °C, from 30 °C to 90 °C, from 30 °C to 50 °C, from 30 °C to 40 °C, from 40 °C to 150 °C, from 40 °C to 120 °C, from 40 °C to 110 °C, from 40 °C to 100 °C, from 40 °C to 90 °C, from 40 °C to 50 °C, from 50 °C to 150 °C, from 50 °C to 120 °C, from 50 °C to 110 °C, from 50 °C to 100 °C, from 50 °C to 90 °C, from 90 °C to 150 °C, from 90 °C to 120 °C, from 90 °C to 110 °C, from 90 °C to 100 °C, from 100 °C to 150 °C, from 100 °C to 120 °C, from 100 °C to 110 °C, from 110 °C to 150 °C, from 110 °C to 120 °C, or from 120 °C to 150 °C. Generally, the gas-phase polymerization reactor may be operated at the highest temperature feasible, taking into account the sintering temperature of the polymer product within the reactor. Regardless of the process used to make the polyethylene or the polyethylene copolymer resin, the reactor temperature should be below the melting or “sintering” temperature of the polymer product. As a result, the upper temperature limit may be the melting temperature of the polymer product.    

[0078] In embodiments, the reactor pressure of the gas-phase polymerization reactor is from 690 kilopascal (kPa) (100 pounds per square inch gauge, psig) to 3,448 kPa (500 psig). For example, the reactor pressure of the gas-phase polymerization reactor may be from 690 kPa (100 psig) to 2,759 kPa (400 psig), from 690 kPa (100 psig) to 2,414 kPa (350 psig), from 690 kPa (100 psig) to 1,724 kPa (250 psig), from 690 kPa (100 psig) to 1,379 kPa (200 psig), from 1,379 kPa (200 psig) to 3,448 kPa (500 psig), from 1,379 kPa (200 psig) to 2,759 kPa (400 psig), from 1,379 kPa (200 psig) to 2,414 kPa (350 psig), from 1,379 kPa (200 psig) to 1,724 kPa (250 psig), from 1,724 kPa (250 psig) to 3,448 kPa (500 psig), from 1,724 kPa (250 psig) to 2,759 kPa (400 psig), from 1,724 kPa (250 psig) to 2,414 kPa (350 psig), from 2,414 kPa (350 psig) to 3,448 kPa (500 psig), from 2,414 kPa (350 psig) to 2,759 kPa (400 psig), or from 2,759 kPa (400 psig) to 3,448 kPa (500 psig). [0079] In embodiments, hydrogen gas may be used in the gas-phase polymerization to control the final properties of the polyethylene or polyethylene copolymer resin. The amount of hydrogen in the polymerization may be expressed as a mole ratio relative to the total polymerizable monomer, such as, for example, ethylene or a blend of ethylene and 1-hexene. The amount of hydrogen used in the polymerization process may be an amount necessary to achieve the desired properties of the polyethylene or polyethylene copolymer resin, such as, for example, melt flow rate (MFR). In embodiments, the mole ratio of hydrogen to total polymerizable monomer (H2:monomer) is greater than 0.0001. For example, the mole ratio of hydrogen to total polymerizable monomer (H ₂ :monomer) may be from 0.0001 to 10, from 0.0001 to 5, from 0.0001 to 3, from 0.0001 to 0.10, from 0.0001 to 0.001, from 0.0001 to 0.0005, from 0.0005 to 10, from 0.0005 to 5, from 0.0005 to 3, from 0.0005 to 0.10, from 0.0005 to 0.001, from 0.001 to 10, from 0.001 to 5, from 0.001 to 3, from 0.001 to 0.10, from 0.10 to 10, from 0.10 to 5, from 0.10 to 3, from 3 to 10, from 3 to 5, or from 5 to 10. [0080] In embodiments, the catalyst systems of the present disclosure may be utilized to polymerize a single type of olefin, producing a homopolymer. However, additional α-olefins may be incorporated into the polymerization scheme in other embodiments. The additional α-olefin comonomers typically have no more than 20 carbon atoms. For example, the catalyst systems of the present disclosure may polymerize ethylene and, optionally, one or more (C3−C12)α-olefin comonomers in a gas phase reactor to produce a polyethylene or a polyethylene copolymer resin. Exemplary (C3−C12)α-olefin comonomers include, but are not limited to, propylene, 1-butene, 1- pentene, 1-hexene, 1-heptene, 1-octene, 1-nonene, 1-decene, and 4-methyl-l-pentene. For example, the one or more (C3−C12)α-olefin co-monomers may be selected from the group    

consisting of propylene, 1-butene, 1-hexene, and 1-octene; or, in the alternative, from the group consisting of 1-hexene and 1-octene. [0081] In embodiments, the one or more (C ₃ −C ₁₂ )α-olefin comonomers, when used, may not be derived from propylene. That is, the one or more (C3−C12)α-olefin comonomers may be substantially free of propylene. The term “substantially free” of a compound means the material or mixture includes less than 1.0 wt.% of the compound. For example, the one or more (C3−C12)α- olefin comonomers, which may be substantially free of propylene, may include less than 1.0 wt.% propylene, such as less than 0.8 wt.% propylene, less than 0.6 wt.% propylene, less than 0.4 wt.% propylene, or less than 0.2 wt.% propylene. [0082] In embodiments, the polyethylene produced, for example homopolymers and/or interpolymers (including copolymers) of ethylene and, optionally, one or more comonomers may include at least 50 mole percent (mol.%) monomer units derived from ethylene. For example, the polyethylene may include at least 60 mol.%, at least 70 mol.%, at least 80 mol.%, or at least 90 mol.% monomer units derived from ethylene. In embodiments, the polyethylene includes from 50 mol.% to 100 mol.% monomer units derived from ethylene. For example, the polyethylene may include from 50 mol.% to 90 mol.%, from 50 mol.% to 80 mol.%, from 50 mol.% to 70 mol.%, from 50 mol.% to 60 mol.%, from 60 mol.% to 100 mol.%, from 60 mol.% to 90 mol.%, from 60 mol.% to 80 mol.%, from 60 mol.% to 70 mol.%, from 70 mol.% to 100 mol.%, from 70 mol.% to 90 mol.%, from 70 mol.% to 80 mol.%, from 80 mol.% to 100 mol.%, from 80 mol.% to 90 mol.%, or from 90 mol.% to 100 mol.% monomer units derived from ethylene. [0083] In embodiments, the polyethylene produced includes at least 90 mol.% monomer units derived from ethylene. For example, the polyethylene may include at least 93 mol.%, at least 96 mol.%, at least 97 mol.%, or at least 99 mol.% monomer units derived from ethylene. In embodiments, the polyethylene includes from 90 mol.% to 100 mol.% monomer units derived from ethylene. For example, the polyethylene may include from 90 mol.% to 99.5 mol.%, from 90 mol.% to 99 mol.%, from 90 mol.% to 97 mol.%, from 90 mol.% to 96 mol.%, from 90 mol.% to 93 mol.%, from 93 mol.% to 100 mol.%, from 93 mol.% to 99.5 mol.%, from 93 mol.% to 99 mol.%, from 93 mol.% to 97 mol.%, from 93 mol.% to 96 mol.%, from 96 mol.% to 100 mol.%, from 96 mol.% to 99.5 mol.%, from 96 mol.% to 99 mol.%, from 96 mol.% to 97 mol.%, from 97 mol.% to 100 mol.%, from 97 mol.% to 99.5 mol.%, from 97 mol.% to 99 mol.%, from 99 mol.% to 100 mol.%, from 99 mol.% to 99.5 mol.%, or from 99.5 mol.% to 100 mol.% monomer units derived from ethylene. [0084] In embodiments, the polyethylene copolymer resin produced includes less than 50 mol.% monomer units derived from one or more (C ₃ −C ₁₂ )α-olefin comonomers. For example, the    

polyethylene copolymer resin may include less than 40 mol.%, less than 30 mol.%, less than 20 mol.% or less than 10 mol.% monomer units derived from one or more (C3−C12)α-olefin comonomers. In embodiments, the polyethylene copolymer resin includes from greater than 0 mol.% to 50 mol.% monomer units derived from one or more (C3−C12)α-olefin comonomers. For example, the polyethylene copolymer resin may include from greater than 0 mol.% to 40 mol.%, from greater than 0 mol.% to 30 mol.%, from greater than 0 mol.% to 20 mol.%, from greater than 0 mol.% to 10 mol.%, from greater than 0 mol.% to 5 mol.%, from greater than 0 mol.% to 1 mol.%, from 1 mol.% to 50 mol.%, from 1 mol.% to 40 mol.%, from 1 mol.% to 30 mol.%, from 1 mol.% to 20 mol.%, from 1 mol.% to 10 mol.%, from 1 mol.% to 5 mol.%, from 5 mol.% to 50 mol.%, from 5 mol.% to 40 mol.%, from 5 mol.% to 30 mol.%, from 5 mol.% to 20 mol.%, from 5 mol.% to 10 mol.%, from 10 mol.% to 50 mol.%, from 10 mol.% to 40 mol.%, from 10 mol.% to 30 mol.%, from 10 mol.% to 20 mol.%, from 20 mol.% to 50 mol.%, from 20 mol.% to 40 mol.%, from 20 mol.% to 30 mol.%, from 30 mol.% to 50 mol.%, from 30 mol.% to 40 mol.%, or from 40 mol.% to 50 mol.% monomer units derived from one or more (C3−C12)α-olefin comonomers. [0085] In embodiments, the polyethylene or polyethylene copolymer resin produced further includes one or more additives. Such additives include, but are not limited to, antistatic agents, color enhancers, dyes, lubricants, pigments, primary antioxidants, secondary antioxidants, processing aids, ultraviolet (UV) stabilizers, and combinations of these. The polyethylene or polyethylene copolymer resin may include any amounts of additives. In embodiments, the produced polyethylene or polyethylene copolymer resin may further include fillers, which may include, but are not limited to, organic or inorganic fillers, such as, for example, calcium carbonate, talc, or Mg(OH)2. [0086] The produced polyethylene or polyethylene copolymer resin may be used in a wide variety of products and end-use applications. The produced polyethylene or polyethylene copolymer resin may also be blended and/or co-extruded with any other polymer. Non-limiting examples of other polymers include linear low density polyethylene, elastomers, plastomers, high pressure low density polyethylene, high density polyethylene, polypropylenes, and the like. The produced polyethylene and blends including the produced polyethylene may be used to produce blow-molded components or products, among various other end uses. The produced polyethylene and blends including the produced polyethylene may be useful in forming operations such as film, sheet, and fiber extrusion and co-extrusion as well as blow molding, injection molding and rotary molding. Films may include blown or cast films formed by coextrusion or by lamination useful as shrink film, cling film, stretch film, sealing films, oriented films, snack packaging, heavy duty    

bags, grocery sacks, baked and frozen food packaging, medical packaging, industrial liners, and membranes in food-contact and non-food contact applications. Fibers may include melt spinning, solution spinning and melt blown fiber operations for use in woven or non-woven form to make filters, diaper fabrics, medical garments, and geotextiles. Extruded articles may include medical tubing, wire and cable coatings, pipe, geomembranes, and pond liners. Molded articles may include single and multi-layered constructions in the form of bottles, tanks, large hollow articles, rigid food containers and toys. Embodiment Combinations [0087] The following are embodiments and combination of embodiments of the present disclosure. A supported catalyst system comprising a metal-ligand complex disposed on one or more support materials, wherein the metal-ligand complex has a structure according to formula (I): I) wherein: M is titanium , zirconium, or hafnium; n is 1, 2, or 3; each X is a monodentate ligand independently chosen from (C ₁ -C ₅₀ )hydrocarbyl, (C1−C50)heterohydrocarbyl, (C6−C50)aryl, (C4−C50)heteroaryl, halogen, –N(R ^N )2, N(R ^N )COR ^C , –OR, –OPh, –OAr and -H; the metal-ligand complex is overall charge-neutral; each Z is independently chosen from –O−, −S−, (C ₆ −C ₅₀ )aryl, (C ₂ −C ₅₀ )heteroaryl, N(C1−C50)hydrocarbyl, N(C1-C50)aryl, P(C1-C50)aryl, and P(C1−C50)hydrocarbyl; R ⁹ and R ¹⁰ are independently chosen from (C ₁ −C ₂₀ )hydrocarbyl, (C1−C20)heterohydrocarbyl and -H; R ¹¹ and R ¹² are independently chosen from halogen, (C1−C20)hydrocarbyl, (C ₁ −C ₂₀ )heterohydrocarbyl and -H; R ¹ −R ⁸ are each independently (C1−C20)hydrocarbyl, (C1−C20)heterohydrocarbyl and -H;     R ¹³ and R ¹⁴ are independently chosen from (C ₁ −C ₂₀ )hydrocarbyl, (C1−C20)heterohydrocarbyl and -H; R ¹⁵ and R ¹⁶ are independently chosen from (C ₁ −C ₂₀ )hydrocarbyl, (C1−C20)heterohydrocarbyl and -H; R ¹⁷ and R ¹⁸ are both: (C1-C20)hydrocarbyl, (C1-C20)heterohydrocarby or - H, where R ^19-23 are independently chosen from (C ₁ −C ₂₀ )hydrocarbyl, (C ₁ −C ₂ carbyl and -H; and Each R, R ^C and R ^N are independently chosen from −H, (C ₁ −C ₅₀ )hydrocarbyl, and (C1−C50)heterohydrocarbyl. In some embodiments, for the supported catalyst system Z is -O-. In some embodiments, for the supported catalyst system n is 2 and each X is methyl. In some embodiments, for the supported catalyst system R ⁹ and R ¹⁰ are each 1,1,-dimethyl-3,3,- dimethylbutyl or t-octyl. In some embodiments, for the supported catalyst system R ¹¹ and R ¹² are each 1,1,-dimethyl-3,3,-dimethylbutyl or t-octyl. In some embodiments, for the supported catalyst system R ¹¹ and R ¹² are each -F. In some embodiments, for the supported catalyst system R ¹ , R ⁴ , R ⁵ and R ⁸ are each tert-butyl and R ² , R ³ , R ⁶ and R ⁷ are each -H. In some embodiments, for the supported catalyst system R ¹ , R ⁴ , R ⁵ and R ⁸ are each -H and R ² , R ³ , R ⁶ and R ⁷ are each tert-butyl. In some embodiments, for the supported catalyst system R ¹⁷ and R ¹⁸ are bot d R ²⁰ and R ²² are each tert-butyl and R ¹⁹ , R ²¹ and R ²³ are each -H. In some em he supported catalyst system R ¹⁷ and R ¹⁸ are both -H. In some embodiments, for the supported catalyst system at least two R groups of R ^19-23 are (C ₁ −C ₂₀ )hydrocarbyl. In some embodiments, for the supported catalyst system R ¹¹ and R ¹² are halogen R ¹ , R ⁴ , R ⁵ and R ⁸ are each independently (C ₁ −C ₂₀ )hydrocarbyl and R ² , R ³ , R ⁶ and R ⁷ are -H or R ¹ , R ⁴ , R ⁵ and R ⁸ are each -H and R ² , R ³ , R ⁶ and R ⁷ are each independently (C1−C20)hydrocarbyl. In some embodiments, for the supported catalyst system the one or more support materials comprise fumed silica. In some embodiments, for the supported catalyst system the supported catalyst system is a spray-dried supported catalyst system. In some embodiments, the supported catalyst system further includes one or more activators. In some embodiments, for the supported catalyst system the activator comprises methylalumoxane (MAO).    

[0088] In some embodiments, the present disclosure also provides for a method for producing a supported activated metal-ligand catalyst, the method comprising: contacting one or more support materials and one or more activators with a metal-ligand complex in an inert hydrocarbon solvent to produce the supported activated metal-ligand catalyst, wherein the metal-ligand complex has a structure according to formula (Ib): R ^{17 18 2 6} R 3 ^R _R ⁷ b) A- is an anion; M is titanium, zirconium, or hafnium; n is 1, 2, or 3; each X is a monodentate ligand independently chosen from (C1-C50)hydrocarbyl, (C ₁ −C ₅₀ )heterohydrocarbyl, (C ₆ −C ₅₀ )aryl, (C ₄ −C ₅₀ )heteroaryl, halogen, –N(R ^N ) ₂ , N(R ^N )COR ^C , –OR, –OPh, –OAr and -H; each Z is independently chosen from –O−, −S−, (C ₆ −C ₅₀ )aryl, (C ₂ −C ₅₀ )heteroaryl, N(C1−C50)hydrocarbyl, N(C1-C50)aryl, P(C1-C50)aryl, and P(C1−C50)hydrocarbyl; R ⁹ and R ¹⁰ are independently chosen from (C ₁ −C ₂₀ )hydrocarbyl, (C1−C20)heterohydrocarbyl and -H; R ¹¹ and R ¹² are independently chosen from halogen, (C1−C20)hydrocarbyl, (C ₁ −C ₂₀ )heterohydrocarbyl and -H; R ¹ −R ⁸ are each independently (C1−C20)hydrocarbyl, (C1−C20)heterohydrocarbyl and -H; R ¹³ and R ¹⁴ are independently chosen from (C ₁ −C ₂₀ )hydrocarbyl, (C1−C20)heterohydrocarbyl and -H; R ¹⁵ and R ¹⁶ are independently chosen from (C ₁ −C ₂₀ )hydrocarbyl, (C1−C20)heterohydrocarbyl and -H;    

R ¹⁷ and R ¹⁸ are both: (C1-C20)hydrocarbyl, (C1-C20)heterohydrocarbyl - H, where R ^19-23 are independently chosen from (C ₁ −C ₂₀ )hydrocarbyl, (C ₁ −C ₂₀ yl and -H; and each R, R ^C and R ^N are independently chosen from −H, (C ₁ −C ₅₀ )hydrocarbyl, and (C1−C50)heterohydrocarbyl. In some embodiments, for the method for producing the supported activated metal-ligand catalyst the one or more activators comprise methylalumoxane (MAO). In some embodiments, the method for producing the supported activated metal-ligand catalyst includes drying the supported activated metal-ligand catalyst, wherein drying includes spray drying the supported activated metal-ligand catalyst to produce particles of a spray-dried supported activated metal-ligand catalyst. In some embodiments, the method for producing the supported activated metal-ligand catalyst further comprises: disposing the one or more activators on the one or more support materials to produce a supported activator; and contacting the supported activator with a solution of the metal-ligand complex in the inert hydrocarbon solvent. In some embodiments, for the method for producing the supported activated metal-ligand catalyst disposing the one or more activators on the one or more support materials comprises spray drying to produce a spray-dried supported activator. In some embodiments, for the method for producing the supported activated metal-ligand catalyst at least two R groups of R ^19-23 are (C ₁ −C ₂₀ )hydrocarbyl. In some embodiments, for the method for producing the supported activated metal-ligand catalyst R ¹¹ and R ¹² are halogen R ¹ , R ⁴ , R ⁵ and R ⁸ are each independently (C ₁ −C ₂₀ )hydrocarbyl and R ² , R ³ , R ⁶ and R ⁷ are -H or R ¹ , R ⁴ , R ⁵ and R ⁸ are each -H and R ² , R ³ , R ⁶ and R ⁷ are each independently (C1−C20)hydrocarbyl. [0089] In some embodiments, the present disclosure also provides for a process for producing a polyethylene or a polyethylene copolymer resin in a gas phase polymerization reactor comprising: contacting ethylene and, optionally, one or more (C3−C12)α-olefin comonomers with a supported activated metal-ligand catalyst in a gas-phase polymerization reactor, wherein the supported activated metal-ligand catalyst comprises a metal-ligand complex disposed on one or more support materials and one or more activators; wherein the metal-ligand complex has a structure according to formula (Ib):     R ¹⁷ R ¹⁸ A- is an anion; M is titanium, zirconium, or hafnium; n is 1, 2, or 3; each X is a monodentate ligand independently chosen from (C ₁ -C ₅₀ )hydrocarbyl, (C1−C50)heterohydrocarbyl, (C6−C50)aryl, (C4−C50)heteroaryl, halogen, –N(R ^N )2, N(R ^N )COR ^C , –OR, –OPh, –OAr and -H; each Z is independently chosen from –O−, −S−, (C6−C50)aryl, (C2−C50)heteroaryl, N(C ₁ −C ₅₀ )hydrocarbyl, N(C ₁ -C ₅₀ )aryl, P(C ₁ -C ₅₀ )aryl, and P(C ₁ −C ₅₀ )hydrocarbyl; R ⁹ and R ¹⁰ are independently chosen from (C1−C20)hydrocarbyl, (C ₁ −C ₂₀ )heterohydrocarbyl and -H; R ¹¹ and R ¹² are independently chosen from halogen, (C1−C20)hydrocarbyl, (C ₁ −C ₂₀ )heterohydrocarbyl and -H; R ¹ −R ⁸ are each independently (C1−C20)hydrocarbyl, (C1−C20)heterohydrocarbyl and -H; R ¹³ and R ¹⁴ are independently chosen from (C ₁ −C ₂₀ )hydrocarbyl, (C1−C20)heterohydrocarbyl and -H; R ¹⁵ and R ¹⁶ are independently chosen from (C1−C20)hydrocarbyl, (C ₁ −C ₂₀ )heterohydrocarbyl and -H;     R ¹⁷ and R ¹⁸ are both: (C1-C20)hydrocarbyl, (C1-C20)heterohydrocarby or - H, where R ^19-23 are independently chosen from (C ₁ −C ₂₀ )hydrocarbyl, (C ₁ −C ₂ carbyl and -H; and each R, R ^C and R ^N are independently chosen from −H, (C ₁ −C ₅₀ )hydrocarbyl, and (C1−C50)heterohydrocarbyl. In some embodiments, for the process for producing the polyethylene or the  polyethylene copolymer resin in the  gas phase polymerization reactor the one or more activators comprise methylalumoxane (MAO). In some embodiments, for the process for producing the polyethylene or the polyethylene copolymer resin in the gas phase polymerization reactor the supported catalyst system is fed to the gas-phase polymerization reactor in neat form, as a solution, or as a slurry. In some embodiments, for the process for producing the polyethylene or the polyethylene copolymer resin in the gas phase polymerization reactor the supported catalyst system is a spray dried supported catalyst system. In some embodiments, for the process for producing the polyethylene or the polyethylene copolymer resin in the gas phase polymerization reactor at least two R groups of R ^19-23 are (C ₁ −C ₂₀ )hydrocarbyl. In some embodiments, for the process for producing the  polyethylene or the  polyethylene copolymer resin in the  gas phase polymerization reactor R ¹¹ and R ¹² are halogen R ¹ , R ⁴ , R ⁵ and R ⁸ are each independently (C1−C20)hydrocarbyl and R ² , R ³ , R ⁶ and R ⁷ are -H or R ¹ , R ⁴ , R ⁵ and R ⁸ are each -H and R ² , R ³ , R ⁶ and R ⁷ are each independently (C ₁ −C ₂₀ )hydrocarbyl. TEST METHODS Polymerization Activity [0090] Unless indicated otherwise, all polymerization activities (also referred to as Catalyst Productivity) are determined as a ratio of polymer produced to the amount of catalyst added to the reactor and are reported in grams of polymer per grams of catalyst per hour (gPE/gCat/hr). Comonomer Content [0091] Unless indicated otherwise, all comonomer contents (i.e., the amount of comonomer incorporated into a polymer) presently disclosed were determined by rapid FT-IR spectroscopy on dissolved polymer in a Gel Permeation Chromatography (GPC) measurement and are reported in weight percent (wt.%). The comonomer content of a polymer can be determined with respect to polymer molecular weight by use of an infrared detector, such as an IR5 detector, in a GPC measurement, as described in Lee et al., Toward absolute chemical composition distribution    

measurement of polyolefins by high-temperature liquid chromatography hyphenated with infrared absorbance and light scattering detectors, 86 ANAL. CHEM.8649 (2014). High Load Melt Index (I ₂₁ ) [0092] Unless indicated otherwise, all high load melt indices (I21) disclosed herein were measured according to ASTM D1238-10, Method B, at 190 °C and a 21.6 kg load, and are reported in decigrams per minute (dg/min). Melt Index (I ₅ ) [0093] Unless indicated otherwise, all melt indices (I5) disclosed herein were measured according to ASTM D1238-04 at 190 °C and a 5.0 kg load, and are reported in decigrams per minute (dg/min). Melt Index (I ₂ ) [0094] Unless indicated otherwise, all melt indices (I2) disclosed herein were measured according to ASTM D1238-04 at 190 °C and a 2.16 kg load, and are reported in decigrams per minute (dg/min). Melt Temperature (T _m ) [0095] Unless indicated otherwise, all melt temperatures (Tm) disclosed herein were measured according to ASTM D3418-08 and are reported in degrees Celsius (°C). Unless indicated otherwise, a scan rate of 10 degrees Celsius per minute (°C/min) on a 10 milligram (mg) sample was used, and the second heating cycle was used to determine the melt temperature (Tm). Molecular Weight [0096] Unless indicated otherwise, all molecular weights disclosed herein, including weight average molecular weight (M _w ), number average molecular weight (M _n ), and z-average molecular weight (Mz), were measured using conventional gel permeation chromatography (GPC) and are reported in grams per mole (g/mol). [0097] The GPC chromatographic system consisted of a High Temperature Gel Permeation Chromatography (Polymer Laboratories), equipped with a differential refractive index detector (DRI). Three Polymer Laboratories PLgel 10µm Mixed-B columns were used. The nominal flow rate was 1.0 mL/min, and the nominal injection volume was 300 ^L. The various transfer lines, columns, and differential refractometer (the DRI detector) were contained in an oven maintained at 160 ^C. The solvent for the experiment was prepared by dissolving 6 grams of butylated hydroxytoluene as an antioxidant in 4 liters of Aldrich reagent-grade 1,2,4-trichlorobenzene (TCB). The TCB mixture was then filtered through a 0.1 ^m Teflon filter. The TCB was then degassed with an online degasser before entering the GPC instrument.     [0098] The polymer solutions were prepared by placing dry polymer in glass vials, adding the desired amount of TCB, then heating the mixture at 160 ^C with continuous shaking for about 2 hours. All quantities were measured gravimetrically. The injection concentration was from 0.5 to 2.0 mg/ml, with lower concentrations being used for higher molecular weight samples. Prior to running each sample, the DRI detector was purged. The flow rate in the apparatus was then increased to 1.0 ml/minute, and the DRI was allowed to stabilize for 8 hours before injecting the first sample. The molecular weight was determined by combining universal calibration relationship with the column calibration which is performed with a series of monodispersed polystyrene (PS) standards. The Mw was calculated at each elution volume with following equation: l _ogM ^{X ^log(K} X ^{/ K} PS ⁾ ^ ^{^} a PS ^{^} 1 l _og ^M 1 _^ 1 PS where the variables w those with subscript “PS” _{stand for PS. In this method,} ^{aPS ^ 0.67} _and ^{KPS ^0.000175} _{, while} ^{a X} _and ^{K X} _were obtained from published Specif 0.695/0.0 9 fo PE and 0.705/0.0002288 for PP. [0099] The concentration, c, at each point in the chromatogram was calculated from the baseline-subtracted DRI signal, IDRI, using the following equation: ^ _{^ ൌ} ^{^^ ^^ ^^ ^^ ൈ ^^ ^^ ^^ ^^} ^ _{^ ^^} where KDRI is a constant determi RI, and (dn/dc) is the refractive index increment for the system. Specifically, dn/dc = 0.109 for polyethylene. [00100] The mass recovery was calculated from the ratio of the integrated area of the concentration chromatography over elution volume and the injection mass which is equal to the pre-determined concentration multiplied by injection loop volume. EXAMPLES [00101] All solvents and reagents were obtained from commercial sources and used as received unless otherwise noted. Anhydrous toluene, hexanes, tetrahydrofuran, and diethyl ether were purified via passage through activated alumina and, in some cases, Q-5 reactant. Solvents used for experiments performed in a nitrogen-filled glovebox were further dried by storage over activated _{3Å molecular sieves. Glassware for moisture-sensitive reactions was dried in a 150} ^o _{C oven} overnight prior to use. NMR spectra were recorded on Varian 400-MR and VNMRS-500 spectrometers. LC-MS analyses were performed using a Waters e2695 Separations Module    

coupled with a Waters 2424 ELS detector, a Waters 2998 PDA detector, and a Waters 3100 ESI mass detector. LC-MS separations were performed on an XBridge C183.5 μm 2.1x50 mm column using a 5:95 to 100:0 acetonitrile to water gradient with 0.1% formic acid as the ionizing agent. HRMS analyses were performed using an Agilent 1290 Infinity LC with a Zorbax Eclipse Plus C18 1.8μm 2.1x50 mm column coupled with an Agilent 6230 TOF Mass Spectrometer with electrospray ionization. ¹ H NMR data are reported as follows: chemical shift (multiplicity (br = broad, s = singlet, d = doublet, t = triplet, q = quartet, p = pentet, sex = sextet, sept = septet and m = multiplet), integration, and assignment). Chemical shifts for ¹ H NMR data are reported in ppm downfield from internal tetramethylsilane (TMS, δ scale) using residual protons in the deuterated solvent as references. ¹³ C NMR data were determined with ¹ H decoupling, and the chemical shifts are reported downfield from tetramethylsilane (TMS, δ scale) in parts per million (ppm) versus the using residual carbons in the deuterated solvent as references. [00102] Synthesis of Ligand 1: de (0.232 g, 0.2883 mmol, 1.00 eq), Pd(PPh3)4 (33.0 mg, 0.0288 mmol, 0.10 eq), and solid NaOH (0.104 g, 2.595 mmol, 9.00 eq) in a round-bottom flask equipped with a reflux condenser sealed with a rubber septa was evacuated, back-filled with nitrogen, the evacuation/nitrogen re-fill process was repeated three times, then freshly sparged deoxygenated 1,4-dioxane (10 mL) and H ₂ O (2 mL) were added via syringe, and the resultant canary yellow mixture was placed in a mantle heated to 85 °C. After stirring (300 rpm) for 36 hrs, the now black mixture was removed from the mantle, allowed to cool to 23 °C, diluted with CH ₂ Cl ₂ (20 mL), the biphasic mixture was suction filtered through a pad of silica gel, rinsed with CH2Cl2 (4 x 20 mL), the filtrate was concentrated onto celite, and purified via silica gel chromatography; 10% – 40% CH ₂ Cl ₂ in hexanes to afford the protected coupled product as an off-white foam (0.651 g). NMR indicated    

product with minor impurities, and the material was used in the subsequent reaction without further purification. [00104] To a solution the coupled product (0.651 g) from above in 1,4-dioxane and CH ₂ Cl ₂ (12 mL, 1:1) under nitrogen at 23 °C was added aqueous conc. HCl (5 mL, 37% w/w). After stirring (300 rpm) for 16 hrs, the dark golden brown mixture was diluted with water (25 mL) and CH ₂ Cl ₂ (25 mL), the biphasic mixture was poured into a separatory funnel, partitioned, residual organics were extracted with CH ₂ Cl ₂ (2 x 25 mL), combined, dried over solid Na ₂ SO ₄ , decanted, concentrated onto celite, and purified via silica gel chromatography; 10% - 40% CH2Cl2 in hexanes to afford Ligand 1 as an off-white foam (0.459 g, 0.2397 mmol, 83% two steps). NMR indicated product. [00105] ¹ H NMR (500 MHz, CDCl ₃ ) δ 7.80 (s, 4H), 7.75 (d, J = 9.1 Hz, 4H), 7.61 – 7.48 (m, 4H), 7.46 – 7.24 (m, 12H), 6.98 – 6.83 (m, 2H), 6.58 – 6.40 (m, 2H), 5.31 (s, 2H), 3.75 (s, 4H), 1.76 (s, 4H), 1.71 (s, 4H), 1.47 (s, 18H), 1.44 (s, 18H), 1.40 (s, 12H), 1.32 (s, 12H), 1.28 (s, 36H), 1.07 – 0.99 (m, 2H), 0.91 (d, J = 7.4 Hz, 12H), 0.88 (s, 18H), 0.75 (s, 18H). [00106] ¹³ C NMR (126 MHz, CDCl ₃ ) δ 155.52, 150.21, 150.17, 149.51, 146.48, 142.35, 141.19, 138.10, 138.03, 132.58, 130.48, 130.14, 129.91, 129.10, 129.06, 128.75, 126.76, 126.48, 126.43, 126.06, 125.98, 125.04, 123.96, 121.76, 120.38, 110.91, 57.11, 56.95, 56.65, 38.11, 37.97, 35.07, 35.02, 34.91, 34.70, 32.47, 32.33, 32.01, 31.90, 31.77, 31.66, 31.61, 30.93, 18.26, 9.65. [00107] Synthesis of Ligand 2: [ ] so m xture o t e oropnacoate ester ( . g, . mmo , . eq), s- o de (0.254 g, 0.3157 mmol, 1.00 eq), Pd(PPh3)4 (36.0 mg, 0.0316 mmol, 0.10 eq), and solid NaOH (0.114 g, 2.841 mmol, 9.00 eq) in a round-bottom flask equipped with a reflux condenser sealed with a rubber septa was evacuated, back-filled with nitrogen, the evacuation/nitrogen re-fill process was repeated three times, then freshly sparged deoxygenated 1,4-dioxane (10 mL) and H2O (2 mL) were added via syringe, and the resultant canary yellow mixture was placed in a    

mantle heated to 85 °C. After stirring (300 rpm) for 36 hrs, the now black mixture was removed from the mantle, allowed to cool to 23 °C, diluted with CH2Cl2 (20 mL), the biphasic mixture was suction filtered through a pad of silica gel, rinsed with CH ₂ Cl ₂ (4 x 20 mL), the filtrate was concentrated onto celite, and purified via silica gel chromatography; 10% – 40% CH2Cl2 in hexanes to afford the protected coupled product as a golden yellow foam (0.124 g). NMR indicated product with minor impurities, and the material was used in the subsequent reaction without further purification. [00109] To a solution the coupled product (0.124 g) from above in 1,4-dioxane and CH2Cl2 (12 mL, 1:1) under nitrogen at 23 °C was added aqueous conc. HCl (5 mL, 37% w/w). After stirring (300 rpm) for 16 hrs, the dark golden brown mixture was diluted with water (25 mL) and CH2Cl2 (25 mL), the biphasic mixture was poured into a separatory funnel, partitioned, residual organics were extracted with CH2Cl2 (2 x 25 mL), combined, dried over solid Na2SO4, decanted, concentrated onto celite, and purified via silica gel chromatography; 10% - 40% CH ₂ Cl ₂ in hexanes to afford Ligand 2 as a white foam (76.0 mg, 0.0494 mmol, 16% two steps). NMR indicated product. [00110] ¹ H NMR (500 MHz, CDCl3) δ 8.47 (s, 2H), 8.02 (d, J = 8.8 Hz, 4H), 7.94 – 7.63 (m, 4H), 7.55 (d, J = 8.9 Hz, 4H), 7.32 – 7.05 (m, 6H), 6.51 – 6.31 (m, 2H), 6.31 – 6.06 (m, 2H), 4.69 (s, 2H), 3.62 (s, 4H), 1.69 (s, 4H), 1.60 (s, 4H), 1.37 (s, 12H), 1.29 (s, 36H), 1.22 (s, 12H), 0.92 (p, J = 7.6 Hz, 2H), 0.81 (d, J = 7.2 Hz, 12H), 0.75 (s, 18H), 0.59 (s, 18H). [00111] ¹³ C NMR (126 MHz, CDCl ₃ ) δ 155.68, 149.38, 147.28, 141.45, 140.22, 132.94, 130.50, 130.02, 129.90, 129.10, 128.16, 126.63, 126.11, 125.86, 125.58, 124.29, 123.94, 121.16, 110.23, 56.84, 56.82, 55.39, 37.96, 37.70, 35.03, 32.47, 32.19, 32.03, 31.91, 31.73, 31.47, 30.96, 18.24, 9.54.    

[00112] Synthesis of Ligand 3 de (0.236 g, 0.3157 mmol, 1.00 eq), Pd(PPh3)4 (36.0 mg, 0.0316 mmol, 0.10 eq), and solid NaOH (0.114 g, 2.841 mmol, 9.00 eq) in a round-bottom flask equipped with a reflux condenser sealed with a rubber septa was evacuated, back-filled with nitrogen, the evacuation/nitrogen re-fill process was repeated three times, then freshly sparged deoxygenated 1,4-dioxane (10 mL) and H2O (2 mL) were added via syringe, and the resultant canary yellow mixture was placed in a mantle heated to 85 °C. After stirring (300 rpm) for 36 hrs, the now black mixture was removed from the mantle, allowed to cool to 23 °C, diluted with CH2Cl2 (20 mL), the biphasic mixture was suction filtered through a pad of silica gel, rinsed with CH ₂ Cl ₂ (4 x 20 mL), the filtrate was concentrated onto celite, and purified via silica gel chromatography; 10% – 40% CH2Cl2 in hexanes to afford the protected coupled product as a golden yellow foam (54.0 mg). NMR indicated product with minor impurities. The impure material was used the subsequent reaction without further purification. [00114] To a solution the coupled product (54.0 mg) from above in 1,4-dioxane and CH2Cl2 (12 mL, 1:1) under nitrogen at 23 °C was added aqueous conc. HCl (3 mL, 37% w/w). After stirring (300 rpm) for 16 hrs, the dark golden brown mixture was diluted with water (25 mL) and CH ₂ Cl ₂ (25 mL), the biphasic mixture was poured into a separatory funnel, partitioned, residual organics were extracted with CH2Cl2 (2 x 25 mL), combined, dried over solid Na2SO4, decanted, concentrated onto celite, and purified via silica gel chromatography; 10% - 40% CH2Cl2 in hexanes to afford Ligand 3 as a white solid (40.4 mg, 0.0273 mmol, 9% two steps). NMR indicated product. [00115] ¹ H NMR (400 MHz, CDCl ₃ ) δ 8.44 (s, 2H), 8.00 (d, J = 8.9 Hz, 4H), 7.71 (s, 4H), 7.53 (dd, J = 8.9, 1.9 Hz, 4H), 7.29 (td, J = 15.1, 2.4 Hz, 6H), 6.84 (dd, J = 8.7, 2.5 Hz, 2H), 6.33 (d, J    

= 8.6 Hz, 2H), 5.19 (s, 2H), 3.48 (s, 4H), 1.74 (s, 4H), 1.70 (s, 4H), 1.40 (s, 12H), 1.34 (s, 12H), 1.27 (s, 36H), 0.80 (s, 18H), 0.69 (s, 18H), -0.16 (s, 6H). [00116] ¹³ C NMR (101 MHz, CDCl ₃ ) δ 155.22, 149.23, 147.25, 142.02, 140.71, 133.13, 130.50, 130.09, 129.96, 129.74, 129.01, 128.06, 126.31, 126.27, 126.22, 125.39, 124.50, 124.27, 121.10, 110.57, 58.58, 57.00, 56.85, 38.04, 37.85, 34.97, 32.49, 32.31, 32.10, 31.95, 31.82, 31.60, 30.89, -6.31.       [00117] Synthesis of Intermediates for Ligands 1 through 3: [00118] Boropinacolate Ester Intermediate of Ligand 1 [001 ried using anhydrous toluene (4 x 10 mL). In a continuous purge, nitrogen filled glovebox, a clear golden yellow solution of the protected phenol (2.306 g, 3.111 mmol, 1.00 eq) in anhydrous deoxygenated THF (50 mL) was placed in a freezer cooled to -35 °C for 2 hrs, upon which a solution of n-BuLi (2.50 mL, 6.223 mmol, 2.00 eq, 2.5 M in hexanes) was added via syringe in a quick dropwise manner. The now darker golden-brown solution was allowed to sit in the freezer for 1 hr, removed, stirred (300 rpm) at 23 °C for 2.5 hrs, the now dark golden yellow solution was placed back in the freezer cooled to -35 °C for 1 hr, and neat isopropoxyboropinacolate (1.90 mL, 9.333 mmol, 3.00 eq) was then added neat via syringe in a quick dropwise manner. The now white mixture was removed from the freezer, and stirred (300 rpm) at 23 °C for 3 hrs. The white mixture was removed from the glovebox, diluted with water (50 mL), THF was removed via rotary evaporation, the biphasic mixture was diluted with CH ₂ Cl ₂ (50 mL), poured into a separatory funnel, partitioned, organics were washed with water (1 x 25 mL), residual organics were extracted from the aqueous (2 x 25 mL), combined, dried over solid Na ₂ SO ₄ , decanted, and concentrated to afford the boropinacolate ester as an off-white foam (2.650 g, 3.056 mmol, 98%). NMR indicated product. The crude material was used in the subsequent reaction without further purification. [00120] ¹ H NMR (500 MHz, cdcl3) δ 7.93 (d, J = 2.6 Hz, 1H), 7.67 (dd, J = 2.0, 0.6 Hz, 2H), 7.62 (dd, J = 9.2, 0.6 Hz, 2H), 7.52 (t, J = 1.9 Hz, 1H), 7.47 (d, J = 2.7 Hz, 1H), 7.39 (dd, J = 9.2, 2.0 Hz, 2H), 7.36 – 7.34 (m, 1H), 7.23 (t, J = 1.6 Hz, 1H), 4.76 (s, 2H), 2.17 (q, J = 7.0 Hz, 2H), 1.76 (s, 2H), 1.41 (s, 9H), 1.41 (s, 6H), 1.40 (s, 9H), 1.38 (s, 12H), 1.26 (s, 18H), 0.83 (s, 9H), 0.19 (t, J = 7.0 Hz, 3H). [00121] ¹³ C NMR (126 MHz, cdcl3) δ 159.23, 150.24, 150.08, 146.45, 145.01, 138.09, 137.71, 134.42, 134.31, 133.37, 131.83, 129.73, 128.64, 127.02, 126.09, 125.86, 123.95, 121.34, 120.29,    

99.18, 83.58, 64.00, 56.85, 38.36, 35.00, 34.94, 34.88, 32.48, 32.03, 31.75, 31.64, 31.63, 30.89, 24.86, 13.81 [00122] Synthesis of Aryl Anthracene Intermediate to Ligand 1 [001 q), aryl iodide (1.370 g, 3.510 mmol, 1.00 eq), Pd(AmPhos)Cl2 (0.249 g, 0.3510 mmol, 0.10 eq), and solid K ₃ PO ₃ (3.725 g, 17.550 mmol, 5.00 eq) in a round-bottom flask equipped with a reflux condenser sealed with a rubber septa was evacuated, back-filled with nitrogen, the evacuation/nitrogen re- fill process was repeated three times, then freshly sparged deoxygenated 1,4-dioxane (30 mL) and H2O (6 mL) were added via syringe, and the resultant canary yellow mixture was placed in a mantle heated to 85 °C. After stirring (300 rpm) for 42 hrs, the now dark purple/black mixture was removed from the mantle, allowed to cool to 23 °C, diluted with CH2Cl2 (25 mL), the biphasic mixture was suction filtered through a pad of silica gel, rinsed with CH ₂ Cl ₂ (4 x 30 mL), the filtrate was concentrated onto celite, and purified via silica gel chromatography; hexanes – 10% CH2Cl2 in hexanes to afford the protected aryl anthracene as a golden yellow foam (2.306 g, 3.111 mmol, 87%). NMR indicated product. [00124] ¹ H NMR (400 MHz, cdcl ₃ ) δ 7.75 (dd, J = 2.0, 0.7 Hz, 2H), 7.63 (dd, J = 9.2, 0.7 Hz, 2H), 7.55 (t, J = 1.9 Hz, 1H), 7.51 (dd, J = 8.7, 2.5 Hz, 1H), 7.41 (dd, J = 9.3, 1.9 Hz, 3H), 7.37 – 7.31 (m, 3H), 4.98 (s, 2H), 3.29 (q, J = 7.1 Hz, 2H), 1.76 (s, 2H), 1.45 (s, 9H), 1.42 (s, 9H), 1.41 (s, 6H), 1.30 (s, 18H), 1.00 (t, J = 7.1 Hz, 4H), 0.84 (s, 9H). [00125] ¹³ C NMR (101 MHz, cdcl3) δ 153.48, 150.20, 150.13, 146.42, 143.50, 138.03, 137.74, 133.09, 131.01, 129.92, 128.48, 128.35, 126.70, 126.21, 123.75, 121.61, 120.24, 114.97, 93.37, 63.92, 57.06, 38.20, 35.05, 35.03, 34.92, 32.48, 31.96, 31.69, 30.91, 14.92. [00126] Boropinacolate Ester Intermediate to Ligands 2 & 3:    

[00127] r or to t e exper ment, t e start ng protecte p eno was azeotrop ca y dried using anhydrous toluene (4 x 10 mL). In a continuous purge, nitrogen filled glovebox, a clear golden yellow solution of the protected phenol (2.740 g, 4.956 mmol, 1.00 eq) in anhydrous deoxygenated THF (100 mL) was placed in a freezer cooled to -35 °C for 2 hrs, upon which a solution of n-BuLi (4.0 mL, 9.912 mmol, 2.00 eq, 2.5 M in hexanes) was added via syringe in a quick dropwise manner. The now darker golden-brown solution was allowed to sit in the freezer for 1 hr, removed, stirred (300 rpm) at 23 °C for 2.5 hrs, the now dark golden yellow solution was placed back in the freezer cooled to -35 °C for 1 hr, and neat isopropoxyboropinacolate (3.0 mL, 14.868 mmol, 3.00 eq) was then added neat via syringe in a quick dropwise manner. The now white mixture was removed from the freezer, and stirred (300 rpm) at 23 °C for 3 hrs. The white mixture was removed from the glovebox, diluted with water (50 mL), THF was removed via rotary evaporation, the biphasic mixture was diluted with CH2Cl2 (50 mL), poured into a separatory funnel, partitioned, organics were washed with water (1 x 25 mL), residual organics were extracted from the aqueous (2 x 25 mL), combined, dried over solid Na2SO4, decanted, and concentrated to afford the boropinacolate ester as a canary yellow foam (3.274 g, 4.823 mmol, 97%). NMR indicated product. The crude material was used in the subsequent reaction without further purification. [00128] ¹ H NMR (500 MHz, cdcl3) δ 8.35 (s, 1H), 7.93 (dt, J = 8.7, 0.7 Hz, 2H), 7.89 (d, J = 2.6 Hz, 1H), 7.53 (dt, J = 1.8, 0.8 Hz, 2H), 7.50 (dd, J = 8.8, 1.9 Hz, 2H), 7.42 (d, J = 2.7 Hz, 1H), 4.65 (s, 2H), 2.23 (q, J = 7.1 Hz, 2H), 1.75 (s, 2H), 1.40 (s, 6H), 1.38 (s, 12H), 1.27 (s, 18H), 0.77 (s, 9H), 0.25 (t, J = 7.1 Hz, 3H). [00129] Synthesis of aryl anthracene intermediate to Ligands 2 & 3:    

[0 ] p ( g, , q), y iodide (2.856 g, 7.317 mmol, 1.00 eq), Pd(AmPhos)Cl ₂ (0.518 g, 0.7317 mmol, 0.10 eq), and solid K ₃ PO ₃ (7.766 g, 36.585 mmol, 5.00 eq) in a round-bottom flask equipped with a reflux condenser sealed with a rubber septa was evacuated, back-filled with nitrogen, the evacuation/nitrogen re-fill process was repeated three times, then freshly sparged deoxygenated 1,4-dioxane (60 mL) and H ₂ O (12 mL) were added via syringe, and the resultant canary yellow mixture was placed in a mantle heated to 85 °C. After stirring (300 rpm) for 42 hrs, the now dark purple/black mixture was removed from the mantle, allowed to cool to 23 °C, diluted with CH ₂ Cl ₂ (25 mL), the biphasic mixture was suction filtered through a pad of silica gel, rinsed with CH2Cl2 (4 x 30 mL), the filtrate was concentrated onto celite, and purified via silica gel chromatography; hexanes – 10% CH ₂ Cl ₂ in hexanes to afford the protected aryl anthracene as a golden yellow foam (2.740 g, 4.956 mmol, 68%). NMR indicated product. [00131] ¹ H NMR (500 MHz, cdcl3) δ 8.37 (s, 1H), 7.98 – 7.94 (m, 2H), 7.54 – 7.50 (m, 4H), 7.46 (dd, J = 8.7, 2.5 Hz, 1H), 7.32 – 7.27 (m, 2H), 4.93 (s, 2H), 3.26 (q, J = 7.1 Hz, 2H), 1.73 (s, 2H), 1.38 (s, 6H), 1.26 (s, 18H), 0.97 (t, J = 7.1 Hz, 3H), 0.76 (s, 9H). [00132] ¹³ C NMR (126 MHz, cdcl3) δ 153.47, 147.00, 143.05, 133.90, 130.81, 130.46, 129.71, 127.92, 127.60, 126.43, 125.01, 124.11, 121.09, 114.32, 93.23, 63.72, 56.61, 38.11, 34.95, 32.46, 32.09, 31.98, 30.88, 14.96. [00133] Synthesis of Protected Iodophenol [00134] 09 mmol, 1.00 eq) in THF (100 mL) was sparged under positive flow of nitrogen for 15 mins upon which an aqueous solution of NaOH (1.8 mL, 22.214 mmol, 1.50 eq, 50 % w/w) was added via syringe in    

a quick dropwise manner. After stirring (500 rpm) for 30 mins at 23 °C, neat chloromethyl ethyl ether (2.7 mL, 29.618 mmol, 2.00 eq) was added via syringe in a quick dropwise manner to the clear colorless solution. After stirring for 2 hrs at 23 °C, the now white heterogeneous mixture was diluted with aqueous NaOH (50 mL, 1 N), THF was removed via rotary evaporation, the resultant white biphasic mixture was diluted with CH ₂ Cl ₂ (100 mL), poured into a separatory funnel, partitioned, organics were washed with aqueous NaOH (2 x 50 mL, 1 N), residual organics were extracted from the aqueous (2 x 25 mL), combined, dried over solid Na ₂ SO ₄ , decanted, and concentrated. The resultant pale yellow oil was diluted in CH2Cl2 (20 mL), suction filtered through a silica gel pad, rinsed with CH ₂ Cl ₂ (4 x 25 mL), and the filtrate was concentrated to afford the phenolic methyl ethyl ether as a clear colorless oil (5.720 g, 14.661 mmol, 99%). NMR indicated pure product. [00135] ¹ H NMR (500 MHz, cdcl3) δ 7.73 (d, J = 2.4 Hz, 1H), 7.29 – 7.23 (m, 1H), 6.99 (d, J = 8.7 Hz, 1H), 5.25 (s, 2H), 3.77 (q, J = 7.1 Hz, 2H), 1.68 (s, 2H), 1.32 (s, 6H), 1.22 (t, J = 7.1 Hz, 3H), 0.73 (s, 9H). [00136] ¹³ C NMR (126 MHz, cdcl ₃ ) δ 153.81, 145.77, 137.11, 127.19, 114.24, 93.80, 86.82, 64.58, 56.86, 37.97, 32.36, 31.82, 31.50, 15.08. [00137] Synthesis of Bromo-di-t-Butylanthracene Me O Me Bu [001 5 mmol, 1.00 eq) in CH2Cl2/MeCN (150 mL, 1:1) at 23 °C was added solid dibromo-dimethylhydantoin (2.461 g, 8.607 mmol, 0.50 eq) all at once. The now dark golden yellow suspension was stirred (500 rpm) for 90 mins upon which the mixture was concentrated onto Celite ^® , and purified via silica gel chromatography using hexanes as the eluent to afford the bromo-di-t-butylanthracene as an off-white powder (6.167 g, 16.698 mmol, 97%). NMR indicated pure product. [00139] ¹ H NMR (400 MHz, Chloroform-d) δ 8.40 (dt, J = 1.6, 0.7 Hz, 2H), 8.31 (s, 1H), 7.90 (dt, J = 8.9, 0.6 Hz, 2H), 7.56 (dd, J = 8.8, 1.8 Hz, 2H), 1.47 (s, 18H). [00140] ¹³ C NMR (101 MHz, Chloroform-d) δ 149.61, 130.53, 130.51, 128.26, 125.81, 124.83, 122.25, 121.90, 35.41, 30.93. [00141] Synthesis of 3,5-di-t-Butylphenyl-bis-t-Butylanthracene    

)Cl2 (0.119 g, 0.1687 mmol, 0.10 eq), K ₃ PO ₄ (1.611 g, 7.590 mmol, 4.50 eq), and the boropinacolate ester (0.800 g, 2.530 mmol, 1.50 eq) was evacuated, then back-filled with nitrogen, this was repeated 4x more, then freshly sparged deoxygenated 1,4-dioxane (15 mL) and water (1.5 mL) was added, the canary yellow mixture was placed in a mantle heated to 50 °C, after stirring for 6 hrs the now purple-black mixture was diluted with CH2Cl2 (20 mL), suction filtered through a pad of silica gel, rinsed with CH ₂ Cl ₂ (4 x 20 mL), the filtrate was concentrated onto celite, and purified via silica gel chromatography; hexanes to afford the 3,5-di-t-butylphenyl-bis-t-butylanthracene as a white foam (0.791 g, 1.653 mmol, 98%). NMR indicated pure product. [00143] ¹ H NMR (400 MHz, Chloroform-d) δ 8.40 (s, 1H), 8.00 (dd, J = 8.9, 0.6 Hz, 2H), 7.77 (dt, J = 1.8, 0.8 Hz, 2H), 7.60 – 7.56 (m, 3H), 7.38 (d, J = 1.8 Hz, 2H), 1.46 (s, 18H), 1.36 (s, 18H). [00144] ¹³ C NMR (101 MHz, Chloroform-d) δ 150.24, 147.03, 137.89, 137.64, 130.23, 129.88, 128.00, 126.02, 125.01, 124.13, 122.16, 121.44, 120.43, 35.09, 35.04, 31.69, 30.98. [00145] Synthesis of Bromoanthracene Intermediate [ 0 eq) in CH2Cl2/MeCN (100 mL, 1:1) at 23 °C was added solid dibromo-dimethylhydantoin (0.800 g, 2.796 mmol, 0.53 eq) all at once. The golden yellow suspension was stirred (500 rpm) for 4 hrs upon which TLC indicated full conversion of the starting anthracene. The solution was concentrated onto celite, and purified via silica gel chromatography; hexanes to afford the bromoanthracene as a white foam (2.740 g, 4.913 mmol, 93%). NMR indicated pure product.    

[00147] ¹ H NMR (400 MHz, Chloroform-d) δ 8.58 (d, J = 9.3 Hz, 2H), 7.75 (d, J = 1.8 Hz, 2H), 7.72 (dd, J = 9.2, 2.0 Hz, 2H), 7.62 (t, J = 1.8 Hz, 1H), 7.36 (d, J = 1.8 Hz, 2H), 1.47 (s, 18H), 1.36 (s, 18H). [00148] ¹³ C NMR (101 MHz, Chloroform-d) δ 150.47, 147.34, 138.56, 137.38, 131.17, 128.66, 127.50, 125.96, 125.88, 122.17, 122.02, 120.74, 35.06, 34.95, 31.68, 30.88. Synthesis of Anthracenyl Boropinacolate Ester Intermediate [00 tane) in anhydrous deoxygenated hexanes (50 mL) in a nitrogen filled glovebox at -35 °C (precooled for 16 hrs) was added the solid anthracenylbromide (2.740 g, 4.913 mmol, 1.00 eq). Then, precooled Et2O (20 mL) was added in a quick dropwise manner while stirring vigorously (1000 rpm). The now dark brown mixture was allowed to sit in the freezer (-35 °C) for 4 hrs upon which neat i- PrOBPin (3.0 mL, 14.739 mmol, 3.00 eq) was added via syringe to the now red-brown mixture. The now pale yellow heterogeneous mixture was allowed to stir at 23 °C for 3 hrs, the mixture was removed from the glovebox, water (20 mL) and Et2O (30 mL) were added sequentially, the biphasic mixture was stirred for 2 mins, poured into a separatory funnel, partitioned, organics were washed with water (2 x 25 mL), residual organics were extracted with Et2O (2 x 25 mL), combined, dried over solid Na ₂ SO ₄ , decanted, concentrated, the resultant pale yellow mixture was suspended in CH2Cl2 (20 mL), suction filtered through silica gel, rinsed with CH2Cl2 (4 x 25 mL), and the resulting filtrate solution was concentrated to afford the anthracenyl boropinacolate ester as a pale yellow foam (2.882 g, 4.766 mmol, 97%). NMR indicated product. [00150] ¹ H NMR (500 MHz, Chloroform-d) δ 8.49 (dd, J = 9.1, 0.6 Hz, 2H), 7.70 (dd, J = 2.1, 0.7 Hz, 2H), 7.61 (dd, J = 9.2, 2.1 Hz, 2H), 7.56 (t, J = 1.9 Hz, 1H), 7.31 (d, J = 1.8 Hz, 2H), 1.62 (s, 12H), 1.43 (s, 18H), 1.32 (s, 18H). [00151] ¹³ C NMR (126 MHz, Chloroform-d) δ 150.88, 150.20, 146.33, 140.60, 138.05, 134.05, 129.79, 128.08, 125.82, 124.53, 122.14, 121.98, 121.11, 120.40, 84.15, 35.00, 34.89, 31.66, 30.89, 25.22.    

[00152] Synthesis of Bis-Iodide Intermediate to Ligand 2 [00153] A s mol, 2.20 eq) and K2CO3 (4.983 g, 36.054 mmol, 6.00 eq) under nitrogen was suspended in DMSO (50 mL), bis- chloromethyl di-isopropyl silane (1.885 g, 6.009 mmol, 1.00 eq, approx. 68% pure) was added neat, and the mixture was placed in a mantle heated to 60 °C. After stirring (300 rpm) for 48 hrs, the golden brown solution was heated to 100 °C, stirred for 24 hrs, removed from the mantle, allowed to cool to ambient temperature, the resultant golden brown mixture was diluted with water (50 mL) and hexanes (50 mL), the biphasic mixture was poured into a separatory funnel, partitioned, organics were washed with aqueous NaOH (2 x 25 mL, 1 N), residual organics were extracted with hexanes (2 x 25 mL), combined, dried over solid Na2SO4, decanted, concentrated onto celite, and purified via silica gel chromatography; 0% - 10% CH ₂ Cl ₂ in hexanes to afford the bis-iodide as a clear colorless amorphous oil (3.506 g, 4.357 mmol, 73%). NMR indicated product. [00154] ¹ H NMR (500 MHz, cdcl ₃ ) δ 7.71 (d, J = 2.3 Hz, 2H), 7.28 (dd, J = 8.6, 2.4 Hz, 2H), 6.90 (d, J = 8.7 Hz, 2H), 3.96 (s, 4H), 1.68 (s, 4H), 1.49 – 1.40 (m, 2H), 1.32 (s, 12H), 1.22 (d, J = 7.4 Hz, 12H), 0.74 (s, 18H). [00155] ¹³ C NMR (126 MHz, cdcl3) δ 157.36, 144.35, 137.02, 126.96, 110.19, 85.84, 56.83, 56.77, 37.89, 32.37, 31.88, 31.60, 18.38, 9.94. [00156] Synthesis of Bis-Iodide Intermediate to Ligand 3 [00157] A so mmol, 2.10 eq) and K2CO3 (3.566 g, 25.800 mmol, 6.00 eq) under nitrogen was suspended in Me2CO (50 mL), bis- chloromethyl dimethylsilane (0.63 mL, 4.300 mmol, 1.00 eq) was added neat, and the mixture was placed in a mantle heated to 60 °C. After stirring (300 rpm) for 48 hrs, the golden brown    

solution was removed from the mantle, allowed to cool to ambient temperature, the resultant golden brown mixture was diluted with hexanes (50 mL), the biphasic mixture was suction filtered through a pad of celite, rinsed with hexanes (4 x 20 mL), the resultant golden brown filtrate solution was concentrated onto celite, and purified via silica gel chromatography; 0% - 10% CH ₂ Cl ₂ in hexanes to afford the bis-iodide as a clear colorless viscous oil (2.263 g, 3.023 mmol, 70%). NMR indicated product. [00158] ¹ H NMR (400 MHz, cdcl ₃ ) δ 7.69 (d, J = 2.3 Hz, 2H), 7.27 – 7.23 (m, 2H), 6.83 (d, J = 8.6 Hz, 2H), 3.83 (s, 4H), 1.66 (s, 4H), 1.30 (s, 12H), 0.71 (s, 18H), 0.39 (s, 6H). [00159] ¹³ C NMR (101 MHz, cdcl ₃ ) δ 156.99, 144.33, 136.90, 127.02, 110.37, 86.07, 59.78, 56.80, 37.87, 32.34, 31.85, 31.63, -5.78. [00160] Synthesis of 2-Iodo-4-t-octyl phenol [00161] A clear co 6.110 mmol, 1.00 eq), KI (3.477 g, 20.943 mmol, 1.30 eq), and aqueous NaOH (21 mL, 20.943 mmol, 1.30 eq, 1 N) in methanol (100 mL) and water (50 mL) under nitrogen was placed in an ice bath and stirred vigorously for 1 hr, upon which precooled commercial aqueous bleach (26 mL, 20.943 mmol, 1.30 eq, 5.2% w/w) was added in a dropwise manner over 10 mins. The now pale opaque yellow mixture was stirred for 2 hrs at 0 °C, the mixture was removed from the ice water bath, stirred at 23 °C for 3 hrs, solid NaH2PO4 (20 g) was added followed by a saturated aqueous mixture Na2S2O3 (100 mL) to reduce residual iodine and water (100 mL), the mixture was stirred vigorously for 10 mins, diluted with CH2Cl2 (50 mL), the biphasic yellow mixture was poured into a separatory funnel, partitioned, organics were washed with aqueous Na2S2O3 (2 x 50 mL), residual organics were extracted from the aqueous layer using CH ₂ Cl ₂ (2 x 50 mL), combined, dried over solid Na2SO4, decanted, and concentrated onto celite, and purified via silica gel chromatography; hexanes – 10% CH ₂ Cl ₂ to afford the 2-iodo-4-t-octylphenol as a clear colorless amorphous foam (3.240 g, 9.340 mmol, 58%). NMR indicated pure product. [00162] ¹ H NMR (500 MHz, Chloroform-d) δ 7.60 (d, J = 2.3 Hz, 1H), 7.24 (dd, J = 8.5, 2.3 Hz, 1H), 6.90 (dd, J = 8.6, 0.5 Hz, 1H), 5.11 (s, 1H), 1.68 (s, 2H), 1.32 (s, 6H), 0.73 (s, 9H).    

[00163] ¹³ C NMR (126 MHz, Chloroform-d) δ 152.34, 144.65, 135.66, 128.14, 114.23, 85.38, 56.87, 37.93, 32.35, 31.81, 31.55. [00164] Synthesis of Inventive Metal-Ligand Complex 1 (IMLC-1): [ ] r or o e exper men , e gan was azeo ropca y r e us ng o uene x mL). In a continuous purge, nitrogen filled glovebox, to a vigorously stirring (1000 rpm) suspension of ZrCl4 (14.6 mg, 0.0628 mmol, 1.05 eq) at 23 °C in anhydrous deoxygenated toluene (20 mL) was added MeMgBr (90.0 µL, 0.2691 mmol, 4.50 eq, 3.0 M in Et ₂ O) was added via syringe in a quick dropwise manner. After stirring vigorously for 20 seconds, a solution of Ligand 1 (114.5 mg, 0.0598 mmol, 1.00 eq) in toluene (5 mL) was added in a quick dropwise manner to the now dark brown mixture. After stirring for 5 hrs, the black mixture was diluted with hexanes (10 mL), stirred vigorously for 2 mins, filtered through a 0.45 µm PTFE filter connected to a 0.20 µm PTFE filter, rinsed with toluene (3 x 5 mL, 1:1), the clear pale yellow solution was concentrated in vacuo, suspended in anhydrous deoxygenated hexanes (3 mL), concentrated, re-suspended in hexanes (3 mL), and concentrated. The resultant amorphous foam was suspended in toluene (5 mL), filtered through a 0.45 µm PTFE filter connected to a 0.20 µm PTFE filter, rinsed with toluene (3 x 5 mL, 1:1), and the filtrate solution was concentrated to afford IMLC-1 as a pale yellow foam (111.3 mg, 0.0547 mmol, 91%). NMR indicated product. [00166] ¹ H NMR (400 MHz, C ₆ D ₆ ) δ 8.64 (d, J = 9.3 Hz, 2H), 8.46 (d, J = 2.0 Hz, 2H), 8.17 (d, J = 9.3 Hz, 2H), 7.92 (d, J = 2.0 Hz, 2H), 7.85 (d, J = 2.5 Hz, 2H), 7.76 – 7.71 (m, 6H), 7.69 – 7.62 (m, 8H), 6.83 (dd, J = 8.7, 2.5 Hz, 2H), 6.79 (dd, J = 9.3, 2.0 Hz, 2H), 4.97 (d, J = 8.6 Hz, 2H), 4.62 (d, J = 14.5 Hz, 2H), 3.48 (d, J = 14.5 Hz, 2H), 1.95 (d, J = 10.2 Hz, 2H), 1.92 (d, J = 10.2 Hz, 2H), 1.83 (d, J = 14.5 Hz, 2H), 1.73 (d, J = 18.0 Hz, 2H), 1.50 (s, 18H), 1.43 (s, 18H), 1.42 – 1.33 (m, 2H), 1.40 (s, 12H), 1.38 (s, 18H), 1.37 (s, 12H), 1.36 (s, 18H), 1.04 (s, J = 7.4 Hz, 12H), 1.03 (s, 18H), 0.84 (s, 18H), -1.29 (s, 6H).    

[00167] ¹³ C NMR (101 MHz, C ₆ D ₆ ) δ 156.94, 156.40, 150.40, 150.35, 147.20, 145.93, 145.34, 139.63, 139.18, 137.80, 134.39, 131.27, 130.91, 130.54, 130.50, 130.13, 129.69, 129.15, 128.45, 128.31, 127.01, 126.70, 126.26, 126.07, 124.49, 123.03, 122.21, 120.92, 120.55, 119.99, 69.40, 57.42, 56.52, 39.24, 38.03, 38.01, 34.91, 34.85, 34.77, 34.54, 32.66, 32.40, 32.25, 32.19, 32.04, 31.78, 31.63, 31.41, 31.34, 30.89, 30.75, 30.28, 29.85, 18.01, 9.23. [00168] Synthesis of IMLC-2: [ ] r or to t e exper ment, t e gan was azeotropca y r e us ng to uene ( x mL). In a continuous purge, nitrogen filled glovebox, to a vigorously stirring (1000 rpm) suspension of HfCl ₄ (20.0 mg, 0.0626 mmol, 1.10 eq) at 23 °C in anhydrous deoxygenated toluene (20 mL) was added MeMgBr (90.0 µL, 0.2691 mmol, 4.50 eq, 3.0 M in Et2O) was added via syringe in a quick dropwise manner. After stirring vigorously for 20 seconds, a solution of Ligand 1 (109.0 mg, 0.0569 mmol, 1.00 eq) in toluene (5 mL) was added in a quick dropwise manner to the now dark brown mixture. After stirring for 5 hrs, the black mixture was diluted with hexanes (10 mL), stirred vigorously for 2 mins, filtered through a 0.45 µm PTFE filter connected to a 0.20 µm PTFE filter, rinsed with toluene (3 x 5 mL, 1:1), the clear pale yellow solution was concentrated in vacuo, suspended in anhydrous deoxygenated hexanes (3 mL), concentrated, re-suspended in hexanes (3 mL), and concentrated. The resultant amorphous foam was suspended in toluene (5 mL), filtered through a 0.45 µm PTFE filter connected to a 0.20 µm PTFE filter, rinsed with toluene (3 x 5 mL, 1:1), and the filtrate solution was concentrated to afford IMLC-2 as a pale yellow foam (102.5 mg, 0.0483 mmol, 85%). NMR indicated product. [00170] ¹ H NMR (400 MHz, C6D6) δ 8.64 (d, J = 9.3 Hz, 2H), 8.46 (d, J = 2.0 Hz, 2H), 8.12 (d, J = 9.3 Hz, 2H), 7.92 (d, J = 2.0 Hz, 2H), 7.87 (d, J = 2.5 Hz, 2H), 7.75 (t, J = 1.8 Hz, 4H), 7.72 (d, J = 2.4 Hz, 2H), 7.66 (dt, J = 8.5, 1.6 Hz, 6H), 6.84 (dd, J = 8.6, 2.5 Hz, 2H), 6.78 (dd, J = 9.3, 2.0 Hz, 2H), 4.97 (d, J = 8.6 Hz, 2H), 4.71 (d, J = 14.6 Hz, 2H), 3.54 (d, J = 14.6 Hz, 2H), 1.96 (d, J = 6.4 Hz, 2H), 1.92 (d, J = 6.5 Hz, 2H), 1.83 (d, J = 14.5 Hz, 2H), 1.63 (d, J = 14.7 Hz,    

2H), 1.50 (s, 18H), 1.43 (s, 18H), 1.39 (s, 18H), 1.39 (6H), 1.38 (s, 3H), 1.37 – 1.33 (m, 2H), 1.36 (s, 6H), 1.35 (s, 3H), 1.28 (s, 6H), 1.06 – 1.01 (m, 12H), 1.04 (d, J = 1.3 Hz, 18H), 0.84 (s, 18H), -1.52 (s, 6H). [00171] ¹³ C NMR (101 MHz, C6D6) δ 157.21, 156.27, 150.41, 150.36, 147.21, 145.91, 145.52, 139.48, 139.22, 137.79, 134.40, 131.27, 131.02, 130.70, 130.57, 130.49, 129.80, 129.70, 129.17, 128.62, 128.43, 126.70, 126.29, 126.06, 124.47, 122.99, 122.21, 120.93, 120.53, 120.40, 69.98, 57.44, 56.53, 45.59, 38.02, 38.00, 34.92, 34.85, 34.77, 34.54, 32.65, 32.40, 32.19, 32.04, 31.79, 31.63, 31.41, 30.89, 30.28, 30.10, 29.85, 18.01, 17.97, 9.30. [00172] Synthesis of IMLC-3: [ ] r or to t e exper ment, t e gan was azeotropca y r e us ng to uene ( x mL). In a continuous purge, nitrogen filled glovebox, to a vigorously stirring (1000 rpm) suspension of ZrCl4 (10.8 mg, 0.04648 mmol, 1.10 eq) at 23 °C in anhydrous deoxygenated toluene (20 mL) was added MeMgBr (65.0 µL, 0.1944 mmol, 4.60 eq, 3.0 M in Et2O) was added via syringe in a quick dropwise manner. After stirring vigorously for 20 seconds, a solution of Ligand 2 (65.0 mg, 0.0423 mmol, 1.00 eq) in toluene (5 mL) was added in a quick dropwise manner to the now dark brown mixture. After stirring for 5 hrs, the black mixture was diluted with hexanes (5 mL), stirred vigorously for 2 mins, filtered through a 0.45 µm PTFE filter connected to a 0.20 µm PTFE filter, rinsed with toluene (3 x 5 mL, 1:1), the clear pale yellow solution was concentrated in vacuo, suspended in anhydrous deoxygenated hexanes (3 mL), concentrated, re-suspended in hexanes (3 mL), and concentrated. The resultant amorphous foam was suspended in toluene (5 mL), filtered through a 0.45 µm PTFE filter connected to a 0.20 µm PTFE filter, rinsed with toluene (3 x 5 mL, 1:1), and the filtrate solution was concentrated to afford IMLC-3 as an off-white foam (68.8 mg, 0.0415 mmol, 98%). NMR indicated product. [00174] ¹ H NMR (400 MHz, C ₆ D ₆ ) δ 8.55 – 8.51 (m, 2H), 8.36 (s, 2H), 8.23 (d, J = 9.0 Hz, 2H), 8.07 – 8.03 (m, 2H), 7.79 (d, J = 8.9 Hz, 2H), 7.67 – 7.53 (m, 8H), 7.32 (dd, J = 8.9, 1.9 Hz, 2H), 6.94 (dd, J = 8.6, 2.4 Hz, 2H), 5.10 (d, J = 8.6 Hz, 2H), 4.52 (d, J = 14.0 Hz, 2H), 3.47 (d, J = 14.1 Hz, 2H), 1.87 (d, J = 14.6 Hz, 2H), 1.79 (d, J = 14.4 Hz, 2H), 1.72 (d, J = 14.5 Hz, 2H),    

1.66 (d, J = 14.4 Hz, 2H), 1.55 (s, 6H), 1.41 (s, 18H), 1.41 (s, 12H), 1.35 – 1.30 (m, 2H), 1.33 (s, 6H), 1.19 (s, 18H), 0.92 (s, 18H), 0.83 (s, 18H), 0.69 (d, J = 7.3 Hz, 6H), 0.60 (d, J = 7.3 Hz, 6H), -1.60 (s, 6H). [00175] ¹³ C NMR (101 MHz, C6D6) δ 156.73, 155.53, 147.10, 146.37, 145.68, 138.98, 134.86, 131.57, 130.82, 130.79, 130.54, 130.52, 130.25, 130.01, 129.71, 129.12, 129.06, 128.31, 126.45, 125.45, 124.70, 123.35, 122.78, 121.01, 119.29, 67.59, 56.86, 40.03, 37.95, 37.85, 35.00, 34.78, 32.48, 32.41, 32.36, 32.16, 31.91, 31.78, 31.60, 31.02, 30.56, 29.85, 18.26, 18.08, 9.62. [00176] Synthesis of IMLC-4: [ ] r or to t e exper ment, t e gan was azeotropca y r e us ng touene ( x mL). In a continuous purge, nitrogen filled glovebox, to a vigorously stirring (1000 rpm) suspension of ZrCl4 (7.3 mg, 0.03124 mmol, 1.10 eq) at 23 °C in anhydrous deoxygenated toluene (20 mL) was added MeMgBr (44.0 µL, 0.1306 mmol, 4.60 eq, 3.0 M in Et ₂ O) was added via syringe in a quick dropwise manner. After stirring vigorously for 20 seconds, a solution of Ligand 3 (42.1 mg, 0.0284 mmol, 1.00 eq) in toluene (5 mL) was added in a quick dropwise manner to the now dark brown mixture. After stirring for 5 hrs, the black mixture was diluted with hexanes (5 mL), stirred vigorously for 2 mins, filtered through a 0.45 µm PTFE filter connected to a 0.20 µm PTFE filter, rinsed with toluene (3 x 5 mL, 1:1), the clear pale yellow solution was concentrated in vacuo, suspended in anhydrous deoxygenated hexanes (3 mL), concentrated, re-suspended in hexanes (3 mL), and concentrated. The resultant amorphous foam was suspended in toluene (5 mL), filtered through a 0.45 µm PTFE filter connected to a 0.20 µm PTFE filter, rinsed with toluene (3 x 5 mL, 1:1), and the filtrate solution was concentrated to afford IMLC-4 as a white foam (44.2 mg, 0.0276 mmol, 97%). NMR indicated product. [00178] ¹ H NMR (400 MHz, C6D6) δ 8.46 (t, J = 1.2 Hz, 2H), 8.40 (s, 2H), 8.24 (d, J = 9.0 Hz, 2H), 8.16 – 8.14 (m, 2H), 7.83 (d, J = 8.9 Hz, 2H), 7.65 (s, 4H), 7.61 (dd, J = 9.0, 1.9 Hz, 2H), 7.56 (d, J = 2.5 Hz, 2H), 7.36 (dd, J = 8.8, 1.9 Hz, 2H), 6.97 (dd, J = 8.6, 2.5 Hz, 2H), 4.88 (d, J = 8.6 Hz, 2H), 4.42 (d, J = 14.2 Hz, 2H), 3.25 (d, J = 14.1 Hz, 2H), 1.86 – 1.74 (m, 6H), 1.65 (d,     J = 14.4 Hz, 2H), 1.50 (s, 6H), 1.41 (s, 6H), 1.40 (s, 6H), 1.36 (s, 6H), 1.33 (s, 18H), 1.21 (s, 18H), 0.91 (s, 18H), 0.81 (s, 18H), -0.36 (s, 6H), -1.51 (s, 6H). [00179] ¹³ C NMR (101 MHz, C ₆ D ₆ ) δ 156.72, 155.68, 147.12, 146.07, 146.05, 139.12, 134.98, 131.48, 130.90, 130.83, 130.74, 130.58, 129.91, 129.73, 129.70, 128.89, 128.83, 126.29, 125.32, 124.80, 123.41, 123.02, 121.39, 119.25, 70.99, 56.81, 56.66, 40.37, 38.03, 37.87, 34.92, 34.79, 32.37, 32.14, 32.07, 31.98, 31.84, 31.75, 31.27, 30.93, 30.60, 29.85, -6.12. Preparation of Spray-Dried Supported Catalyst Systems: Production of Spray-Dried Supported Catalyst Systems [00180] Prepare the spray-dried supported catalyst systems in a nitrogen-purged glove box as follows. Table 1 contains the amounts of the metal-ligand complex, fumed silica, 10 wt.% MAO solution, and toluene used to make each of the spray-dried supported catalysts of the Examples (EX) and Comparative Examples (CE). [00181] In an oven-dried jar, slurry Cabosil™ TS-610 fumed silica in toluene until well dispersed. Add a 10 % solution by weight of MAO in toluene. Stir the mixture magnetically for 15 minutes, then add the metal-ligand complex (e.g., IMLC-1, IMLC-2, IMLC-3, and IMLC-4) to the resulting slurry and stir the mixture for 30-60 minutes. Spray-dry the mixture using a Buchi Mini Spray Dryer B-290 with the following parameters to yield the spray dried sample: Set Temperature: 185 °C, Outlet Temperature: 100 °C (min.), aspirator setting of 95 rotations per minute (rpm), and pump speed of 150 rpm. Table 1. Quantities of reagents to make the spray-dried supported catalyst systems (sd-Cat) of EX and CE.

CMCL – HN-5 metal-ligand complex commercially available from Univation Technologies having the following structure: Gas‐Phase Batch Reactor Test:  [00182] Use the spray dried catalysts prepared above for ethylene/1-hexene copolymerizations conducted in the gas-phase in a 2L semi-batch autoclave polymerization reactor, as described herein. The individual run conditions and the catalyst productivity and analytical data of the polymer produced in gas phase batch reactor experiments are tabulated and shown on Table 2 and Table 3, below. [00183] Poly(ethylene-co-1-Hexene) Copolymer Resin Production [00184] Gas-phase batch reactor catalyst testing procedure: The gas phase reactor employed is a 2-liter, stainless steel autoclave equipped with a mechanical agitator. For the experimental runs, the reactor was first dried, or “baked out,” for 1 hour by charging the reactor with 200 g of NaCl and heating at 100 °C under nitrogen for 30 minutes. After baking out the reactor, 5 g of spray- dried methylaluminoxane on fumed silica (SDMAO) was added as a scavenger under nitrogen pressure. After adding SDMAO, the reactor was sealed, and the components were stirred. The reactor was then charged with hydrogen and 1-hexene pressurized with ethylene as provided in each Table 2 and 3. Once the system reached a steady state, the catalyst was charged into the reactor at 80 °C to start polymerization. The reactor temperature was then brought to the reaction temperature as seen in each of Table 2 and Table 3, and this temperature was maintained while keeping the ethylene, 1-hexene, and hydrogen feed ratios consistent, according to the respective Table, throughout the 1 hour run. At the end of the run, the reactor was cooled down, vented, and opened. The resulting product mixture was washed with water and methanol, then dried. Polymerization Activity (grams polymer/gram catalyst-hour) was determined as the ratio of polymer produced to the amount of catalyst added to the reactor. Tested Property Results [00185] The semi-batch reactor results for the spray-dried catalysts, sd-Cat-1 thru sd-Cat-9, made from IMLC-1 thru IMLC-4, which contain a Si bridge and substituted anthracenes, are shown in Tables 2 and 3. The productivity for most of the spray-dried catalysts is higher than for the corresponding comparative example, sd-Cat-CMLC (a catalyst benchmark used for medium    

to high density applications), and the efficiency of sd-Cat-1 thru sd-Cat-9 is significantly higher than the benchmark under process relevant conditions (up to approximately 40 times more efficient, Table 2). Also, sd-Cat-1 thru sd-Cat-9 make poly(ethylene-co-1-hexene) copolymer resin having higher weight average molecular weight (Mw) as well as higher molecular weight of the peak maxima (Mp) in combination with higher comonomer incorporation as compared to the poly(ethylene-co-1-hexene) copolymer resin made using sd-Cat-CMLC (Table 3). In addition, the poly(ethylene-co-1-hexene) copolymer resins made with sd-Cat-1 thru sd-Cat-9 exhibit similar advantaged polymer properties including comonomer distribution, MWD, while also having higher native molecular weights. These factors allow for a large range of possible poly(ethylene- co-1-alkene) copolymer resins made using sd-cat-1 through sd-cat-9, including producing medium-to-high density bi- and trimodal resins with a similar-to-improved comonomer delta between low and high molecular segments of the bimodal resin while producing the resin with better productivity. Catalysts sd-Cat-1 through sd-Cat-9 may also possess ultra-high molecular weight (UHMW) capability and significantly higher Mw capability than existing commercial benchmark catalysts used to make high M _w components of a resin (i.e., sd-Cat-CMLC). Currently, this UHMW capability, under process relevant conditions in combination with high productivity and efficiency, is one that our commercial benchmarks do not have.     Data Table 2. Catalyst productivity, efficiency, and melt flow of poly(ethylene-co-1-hexene) copolymers produced in the gas phase batch reactor under high density conditions at 100 °C. Ex. Catalyst Cat. Charge Yield Productivity Efficiency Tab e batch reac tor under high density conditions at 100 °C. Ex. Catalyst Mw (g/mol) PDI Mp Mz (g/mol Wt% C6 SCB / No (Mw/Mn) (g/mol) 1000TC tly limited to the exact numerical values recited. Instead, unless otherwise specified, each such dimension is intended to mean both the recited value and a functionally equivalent range    

surrounding that value. For example, a dimension disclosed as “40 g/cm ³ ” is intended to mean “about 40 g/cm ³ .” [00187] Notations used in the equations included herein refer to their standard meaning as understood in the field of mathematics. For example, “=” means equal to, “×” denotes the multiplication operation, “+” denotes the addition operation, “-” denotes the subtraction operation, “>” is a “greater than” sign, “<” is a “less than” sign, “and “/” denotes the division operation. [00188] Every document cited herein, if any, including any cross-referenced or related patent or patent application and any patent or patent application to which this application claims priority or benefit thereof, is incorporated by reference in its entirety unless expressly excluded or otherwise limited. The citation of any document is not an admission that it is prior art with respect to any embodiment disclosed or claimed, or that it alone, or in any combination with any other reference or references, teaches, suggests, or discloses any such embodiment. Further, to the extent that any meaning or definition of a term in this document conflicts with any meaning or definition of the same term in a document incorporated by reference, the meaning or definition assigned to that term in this document shall govern.